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Summary 
 
Fetuin-B is a hepatic plasma protein, well conserved in mammals. Fetuin-B associates with 
the extracellular matrix and was shown to surround the oocytes during development and 
maturation. A layer of extracellular matrix, the Zona pellucida (ZP), surrounds mammalian 
oocytes. Before fertilization sperm are able to penetrate the ZP. After fertilization proteases 
are released by the oocyte, leading to structural ZP modification and inhibition of further 
sperm binding. This process is called fertilization-triggered ZP hardening. The hardened ZP 
is thought to be required to block polyspermy and to support embryonic development until 
blastocyst hatching and implantation into the uterus wall. Premature, fertilization-independent 
ZP hardening is known to occur spontaneous during in vitro cultivation (IVC), leading to 
decreased fertilization success at in vitro fertilization (IVF).  
It was shown that Fetub-/- females are infertile due to premature ZP hardening. Fetub+/- 
females only had half the serum level of fetuin-B, but were completely fertile. Infertility of 
Fetub-/- females was overcome by laser-assisted IVF and subsequent embryo transfer even 
into fetuin-B deficient foster mothers, showing that fetuin-B is critically required before 
fertilization, but is dispensable during later stages of embryonic and fetal live. Recombinant 
murine fetuin-B was shown to inhibit the proteolytic activity of ovastacin, the oocyte specific 
protease that triggers definitive ZP hardening. Accordingly, recombinant murine fetuin-B 
inhibited ZP hardening and increased IVF success without increasing polyspermy.  
In conclusion, fetuin-B inhibits spontaneously released ovastacin and thus premature ZP 
hardening either in vivo or in vitro, to maintain ZP permeability. After fertilization, the 
precipitous increase of ovastacin concentration triggered by degranulation, overwhelms the 
inhibition capacity of fetuin-B, resulting in fertilization-triggered ZP hardening. Fertilization-
triggered ZP hardening proved less important in blocking polyspermy than thought 
previously. Fetuin-B deficiency either in vivo or in vitro lead to ZP hardening during oocyte 
maturation blocking fertilization. Thus fetuin-B represents a novel target for fertilization 
biology and reproductive medicine.  
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1. Introduction 
1.1 The Protein Fetuin-B and its Biological Function 
Fetuin-B is well conserved in different mammals (for comparison between murine and human 
fetuin-B see table 1) 1. The murine fetuin-B gene (Fetub) has a size of about 21.4 kb and is 
located on chromosome 16. It consists of eight exons, while the coding sequence starts at 
the second exon, leading to a transcript of approximately 1.5 kb 2. In mice, the protein fetuin-
B (FetuB) is almost exclusively expressed in the liver. Low mRNA level could be detected in 
kidney, lung, ovary, tongue and embryo. The murine protein consists of 388 amino acids, 
leading to a theoretical size of 43 kDa. Due to post-translational modifications it has a 
molecular weight of 60 kDa under reducing conditions on SDS-PAGE. Mouse fetuin-B is 
secreted into the blood where it reaches serum concentrations of about 156 ± 3 µg/ml 2. 
Protein extraction after tissue perfusion showed that fetuin-B was present in all tested tissues 
with the exception of the brain. Thus it was assumed that fetuin-B either associates with the 
extracellular matrix or is contained within the cells. 
The human fetuin-B gene (FETUB) has a size of about 13.0 kb and is located on 
chromosome 3, leading to a transcript of approximately 1.6 kb 2. As in mice the protein is 
predominantly expressed in the liver. The fetuin-B transcript could be detected at a lower 
level in human placenta, which was not tested in mice. In contrast to murine data no 
expression was detected in human kidney and lung, while human ovary, tongue and embryo 
were not tested as well. The human protein consists of 382 amino acids, with a theoretical 
molecular weight of 43 kDa and an apparent molecular weight of 55 kDa on reducing SDS-
PAGE. In humans, fetuin-B serum concentration is about 5 ± 1 µg/ml, which is more than 30 
times lower than in mice 2.  
In both species, females show a two-times higher fetuin-B serum level with an increased 
variation than males, indicating sex steroid depended regulation of expression. 
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Table 1. Comparison of murine and human fetuin-B (modified from 2) 
 Mouse Human 
Gene size (kb) 21.4 13.0 
Gene location chromosome 16 
Pos. 22918382-22939768 
chromosome 3 
Pos. 186640360-186653008 
Transcript size (kb) 1.5 1.6 
Organs with transcription 
(lower level) 
liver  
(kidney, lung, ovary, tongue, embryo) 
liver  
(placenta) 
Protein size  
(number of amino acids) 
388 382 
Protein size (kDa) approx. 60 approx. 55 
Serum concentration (µg/ml) 156 ± 3 5 ± 1 
 
The fetuin protein family has a specific N-terminal DXLETXCHXL motif and comprises two 
members: fetuin-A (FetuA, also known as α2-HS-glycoprotein AHSG) and fetuin-B (FetuB) 
3,4. Together with histidine-rich glycoprotein (HRG) and kininogen (KNG), fetuins belong to 
the type 3 cystatin superfamily (figure 1), comprising structurally related protease inhibitors 1. 
They all show at least two aminoterminal cystatin domains and one additional ortholog-
specific domain. Several disulfide bridges that link the domains form the three-dimensional 
protein tertiary structure.  
 
 
Figure 1. Schematic overview of the human type 3 cystatin superfamily that comprises fetuin-A (AHSG), 
fetuin-B (FETUB), histidine-rich glycoprotein (HRG) and kininogen (KNG, with two splice variants leading to high 
(HK) and low (LK) molecular weight). All members show at least two aminoterminal cystatin domains and one 
additional, more specific domain. Several disulfide bridges, indicated by rectangles, link the single domains. 
Numbers of amino acids are given at the right and are further indicated at the scale at the bottom (modified from 
1). 
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The protein alignment shown in figure 2 indicates that sequence identity between fetuin-A 
and fetuin-B is about 26% in mice, and 28% in humans, respectively 5,6. Amino acid identity 
of the fetuin-B coding sequences in mice and humans is 61% and sequence identity of 
fetuin-A in mice and humans is 59%. The fact that identity within the two fetuin-B amino acid 
sequences of both species is higher than the sequence identity to fetuin-A of the same 
species indicates that the duplication of the fetuin gene probably occurred before speciation. 
 
 
Figure 2. Multiple alignment of mouse (m) and human (h) fetuin-B (FetuB) and fetuin-A (FetuA). Species 
and protein are noted on the left. Identical or similar residues conserved in all four sequences are printed as white 
on black background. Red letters indicate similar residues only conserved in fetuin-B of both shown species. A 
minimum number of gaps, indicated by hyphens, has been introduced to maximize alignments. * marks the 
transition from one domain to the next (modified from 4).  
  
mFetuB  -MGLLRLLVLCTLAACCMARSPPAPPLPQRPLSPLHPLGCNDSEVLAVAGFALQNINRDQ 
hFetuB  -MGLLLPLALCILVLCCGAMSPPQ--LALNP-SALLSRGCNDSDVLAVAGFALRDINKDR 
mFetuA  MKSLVLLLCFAQLWGC--------QSAPQGTGLGFRELACDDPEAEQVALLAVDYLNNHL 
hFetuA  MKSLCLLLCLAQLWGC--------HSAPHGPGLIYRQPNCDDPETEEAALVAVDYINQHL 
 
mFetuB  KDGYMLSLNRVHDVREHYQEDMGSLFYLTLDVLETDCHVLSRKAQKDCKPRMFYE-SVYG 
hFetuB  KDGYVLRLNRVNDAQEYRRGGLGSLFYLTLDVLETDCHVLRKKAWQDCGMRIFFE-SVYG 
mFetuA  LQGFKQVLNQIDKVKVWSRRPFGVVYEMEVDTLETTCHALDPTPLANCSVRQLTEHAVEG 
hFetuA  PWQYKHTLNQIDEVKVWPQQPFGEMFEIEIDTLETTCHVLDPFPVAGCRVRQLKEHAVEG 
                                           
mFetuB  QCKAMFHINKPRRVLYLPAYNCTLRPV*SKRKTHTTCPDCPS--PIDLSNPSALEAATES 
hFetuB  QCKAIFYMNNPSRVLYLAAYNCTLRPV*SKKKIYMTCPDCPSSIPTDSSNHQVLEAATES 
mFetuA  DCD--FHILKQDGQFRVMHTQCHSTPD*SAEDVRKLCPRCPLLTPFNDTN--VVHTVNTA 
hFetuA  DCD--FQLLKVNGKFSVVYAKCDSSPD*SAEDVRKVCRDCPLLAPLNDTR--VVHAAEAA 
 
mFetuB  LAKFNSKSPSKKYELVKVTKAMNQWVSGP-AYYVEYLIKEAPCTKSQA---S-CSLQHSD 
hFetuB  LAKYNNENTSKQYSLFKVTRASSQWVVGP-SYFVEYLIKESPCTKSQA---SSCSLQSSD 
mFetuA  LAAFNTQNNGTYFKLVEISRA--QNVPLPVSTLVEFVIAATDCTAKEVTDPAKCNLLAEK 
hFetuA  LAAFNARNNGSNFQLEEISRA--QLVPLPPSTYVEFTISGTDCVAKEATEAANCSLLAKK 
 
mFetuB  SEPVGICQGSTVQSSLRHVPLIQP-VEKSVTVTCEFFESQ*AQVPGDE-NPAVTQGPQKL 
hFetuB  SVPVGLCKGSLTRT----------HWEKFVSVTCDFFESQ*APATGSE-NSAVNQKPTNL 
mFetuA  QH--GFCKANLMHN-LGG---------EEVSVACKLFQTQ*P-----QPANANAVGPVPT 
hFetuA  QY--GFCKATLNEK-LGG---------EEVAVTCTVFQTQ*PATSQPQPEGANEAVPTAV 
 
mFetuB  P------QKNTAPTSSPSVTAPRGSIQHLPELDDEKPEESKGGSPEEAFPVQLDLTTNPQ 
hFetuB  PKVEESQQKNTPPTDSPSKAGPRGSVQYLPDLDDKNSQE-KGP--QEAFPVHLDLTTNPQ 
mFetuA  ----ANAALPAD---------PPASVVVGPVVV---P----RGLSDHRTYHDLRHAFSPV 
hFetuA  VDADAPASYPLGTSEPLSAGDPIDT-----RVFAAAP----PAVPMHSSHYDLRHFFMGV 
 
mFetuB  GDTLDVSFLYLEPGDKKLVVLPF----PGKEQRSAECPGPEKENNPLVLPP          
hFetuB  GETLDISFLFLEPMEEKLVVLPF----PKEKARTAECPGPAQNASPLVLPP 
mFetuA  ASVESASGETLH---SPKVGQPG---AAG--PVSPMCPGRIRHFKI----- 
hFetuA  VSLGSPSGEALHSRKTRSVVQPSVGAAAG--PVVPPCPGRVRHFKV----- 
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Because of the structural relationship and the similar expression pattern it was first assumed 
that fetuin-A and fetuin-B should have similar biological roles in mice. Fetuin-A deficient mice 
are fertile and healthy 7. Depending on the genetic background fetuin-A deficient mice show 
mild calcification (C57BL/6 background) or severe systemic calcification of vital organs 
(DBA/2), indicating that the major physiological function of fetuin-A is the inhibition of 
unwanted calcification 7,8. Bacterially expressed recombinant murine fetuin-A inhibits 
precipitation of calciprotein particles in vitro with an IC50 of approximately 2 µM, while the 
IC50 of fetuin-B was three times higher 2. Taking into account the different serum 
concentrations and molecular weights (in mice: fetuin-A, 14 µM and 55 kDa; fetuin-B, 3 µM 
and 60 kDa), fetuin-A should contribute to the overall serum inhibition precipitation 14 times 
more than fetuin-B in mice and even more in humans. Other studies showed no effect of 
recombinant murine, rat or human fetuin-B on calciprotein particle formation and structural 
analysis of fetuin-B revealed no functional calcium-binding domain 9. Fetuin-B serum 
concentration is twice as high in females than in males, while the amount of fetuin-A is not 
different, indicating different, probably sex steroid-dependent regulation of protein expression 
2. Thus it was concluded, that the two fetuins have similar expression patterns, but different 
physiological functions.  
Various biological functions were proposed for fetuin-B. Genetic association studies 
suggested a role for fetuin-B and HRG in tumor biology 10. Overexpression of fetuin-B in skin 
carcinoma cells suppressed tumor growth in nude mice. Murakami et al. proposed the fetuin-
B gene as a target of the farnesoid X receptor (FXR), a nuclear receptor that is involved in 
lipid and carbohydrate metabolism, especially in certain cancers 11. Activation of the FXR 
increased fetuin-B expression in human hepatocytes but showed no effect in mouse 
hepatocytes. Together with the fact that FXR activation also induces apoptosis in human 
breast cancer cells these results suggested, that the FXR-fetuin-B pathway might regulate 
cancer cell proliferation. Choi at al. suggested a role of fetuin-B in rat fatty acid metabolism 
together with zinc-α2-glycoprotein 12,13. Obesity-resistant rats showed increased plasma 
protein levels of both proteins at high fat diet. The knockdown of both proteins in liver cells 
led to a significant increase in the expression of lipogenic genes, resulting in higher lipid 
levels. Furthermore, fetuin-B scored positive in several microarray expression and proteome 
studies in different animal models 14–16. However, the underlying molecular functions of these 
results have not yet been revealed.  
To study the biological role of fetuin-B in detail, the gene was inactivated in mice by targeted 
Fetub gene deletion 17,18. Hemizygous (Fetub+/-) mice had half the fetuin-B serum level of 
wildtype (Fetub+/+) littermates, and homozygous fetuin-B deficient (Fetub-/-) mice had no 
detectable serum fetuin-B. Serum fetuin-A was not altered. There were no differences found 
in fetuin-B deficient mice compared to wildtype mice in body weight, systolic and diastolic 
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blood pressure, pulse rate and blood chemistry, arguing against a role of fetuin-B in fatty acid 
metabolism. Furthermore, fetuin-B deficient mice showed no pathological calcification. 
However, females were completely infertile. In vivo, fertility was restored by transplanting 
post-pubertal Fetub-/- ovaries into ovariectomized isogenic wildtype recipients. Recipients 
became pregnant after subsequent mating with wildtype males indicating that plasma fetuin-
B was necessary and sufficient to restore fertility of Fetub-/- ovaries. Furthermore, this result 
excluded an early oocyte maturation defect in fetuin-B deficient females. We analyzed 
reproductive tract morphology, follicle development, ovulation rates, hormonal status as well 
as sperm motility and chemoattraction, and detected no difference between Fetub-/- and 
wildtype animals 19. After mating, oocytes recovered from wildtype mice were all fertilized. In 
contrast, the oocytes of female Fetub-/- mice showed no signs of fertilization. Thus, a block of 
fertilization most likely caused the infertility in female Fetub-/- mice. To study the fertilization 
block in more detail, we performed in vitro fertilization (IVF) with and without laser perforation 
of the Zona pellucida (ZP), a layer of extracellular matrix that surrounds mammalian oocytes 
17,19. Conventional IVF of fetuin-B deficient oocytes using fertile sperm remained 
unsuccessful, whereas wildtype oocytes became fertilized. In contrast, laser beam-induced 
perforation of the ZP followed by IVF was met with success. Thus fetuin-B deficient oocytes 
could be fertilized after overcoming the ZP as a barrier and infertility of Fetub-/- females was 
caused by a defect in the ZP. 
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1.2 Gametogenesis in Mammals 
1.2.1 Oogenesis 
The development of the female gamete in the ovaries until ovulation is called oogenesis. It 
comprises three phases: proliferation, growth and maturation (for overview see figure 3). 
In humans, gamete development begins as early as the third to fourth week of embryo 
development 20. In mice, gamete development starts seven days post-fertilization 21. The 
oogonia migrate to the gonadal ridge and start to proliferate (proliferation phase). In humans 
the proliferation period is completed after seven month, giving rise to about seven million 
oogonia at birth 22. For several decades it was thought that the oocyte population was 
determined with the end of the proliferation period. Meanwhile researchers demonstrated 
however, the existence of post-natal oogenesis in adults. These late developing oocytes do 
however, not contribute to the pool of ovulated oocytes 23,24. The majority of the gametes 
already die during proliferation, the rest starts the first meiotic division 25. At this stage the 
female gametes are named primary oocytes. The gametes arrest in the first prophase of 
meiosis until recruitment into the growing pool throughout the reproductive years (figure 3). 
Together with the surrounding precursor granulosa cells primary oocytes build the primordial 
follicles 26. The exact mechanism that leads to further follicle maturation is not completely 
known, yet 27. It was shown, that the bidirectional communication between pre-granulosa 
cells and the oocytes as well as between the pre-granulosa cells and the surrounding tissue 
is very important 28,29. Precursor granulosa cells for example express peptide factors like 
stem cell factor (SCF, also known as Kit ligand) and leukemia inhibitory factor (LIF), which 
stimulate maturation of the primordial follicles in vitro 30,31. Members of the transforming 
growth factor β (TGF-β) family, like bone morphogenetic protein-4 and -7 (BMP4 and BMP7) 
also play an important role in primordial follicle recruitment 32,33. Both are secreted by follicle 
surrounding ovarian stroma. Other members of the TGF-β family, including growth and 
differentiation factor-9 (GDF9) and BMP15, are secreted by the oocytes, and support 
follicular maturation as well. By these mentioned factors at the age of puberty the primordial 
follicle starts to grow and the oocyte surrounding pre-granulosa cells develop to granulosa 
cells (growth phase). The diameter of murine oocytes increases from 15 µm to 80 µm 34. At 
this stage, the follicle is called primary follicle. The follicle cells now expresses anti-müllerian 
hormone (AMH), which also belongs to the TGF-β family and inhibits further recruitment of 
primordial follicles 35. In humans, the blood AMH level signifies ovarian function and predicts 
ovarian response to hormonal stimulation in IVF treatment 36–38. 
Growing oocytes form an outer layer, the Zona pellucida, short ZP. The ZP is up to 7 µm 
thick in mice, and up to 14 µm thick in humans, but still is permeable to large molecules 
including proteins with a molecular weight up to 150 kDa 39. The ZP is perforated by cellular 
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protrusions from the surrounding granulosa cells to allow the exchange of nutrients and other 
signaling molecules 40. 
 
Figure 3. Schematic overview of oogenesis and spermatogenesis, from the migration of the gametes into the 
gonadal ridge through to meiosis, fertilization and the formation of a zygote. In oogenesis only one mature oocyte 
is obtained out of one primary oocyte during meiosis, while in spermatogenesis one primary spermatocyte 
develops into four spermatozoa. In sperm differentiation and maturation starts at the end of meiosis. Oocytes 
already mature during meiosis and the meiosis is not completed until after fertilization (modified from 19). 
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With ongoing follicle maturation, the granulosa cells 
start dividing, and a second surrounding cell layer 
called the thecal cells is formed. These cells also 
express BMP4 and BMP7, indicating that beside 
primordial follicle recruitment, both factors are also 
important for further development 32. When more 
than one granulosa cell layer surrounds the oocytes, 
the complex is called secondary follicle. Next, 
granulosa cells start to proliferate and express 
activin, another member of the TGF-β family, and its 
binding protein follistatin 41. There are three different 
activin isoforms (A, AB, B), depending on the 
composition of the subunits. In rodents, activin-A 
increased the follicle growth up to the antral follicle 
42,43. Depending on the persistence of follistatin 
activin-A increased granulosa cell proliferation 44. Additionally, activin induces the expression 
of follicle stimulating hormone (FSH) receptors in granulosa cells. A comparative function 
was shown for TGF-β, which is additionally expressed by thecal cells 45. In consequence the 
follicles get sensitive for FSH. FSH is released by the anterior lobe of the pituitary gland and 
is regulated by gonadotropin releasing hormone (GnRH) expression in the hypothalamus. At 
the beginning of each female estrus cycle FSH is secreted into the blood. In the ovaries, FSH 
only affects the secondary follicles by further stimulating granulosa cell proliferation. During 
ongoing maturation a fluid filled cavity called antrum, persists in the follicle. The follicular fluid 
is mainly composed of granulosa cell secretions, but also comprises components of blood 
plasma 46. At this stage the follicle is named antral follicle or Graafian follicle (figure 4). 
Granulosa cell protrusions that permeate the ZP are removed and granulosa cells 
differentiate into several distinct subtypes 40. The membrana granulosa forms the wall of the 
ovarian follicle interior to the basal lamina and thus to the thecal cells. The inner layer that 
surrounds the growing oocyte is called corona radiata. A structure called cumulus oophorous 
surrounds the corona radita and thus connects the oocyte to the membrana. During the early 
antral stage of folliculogenesis, the level of luteinizing hormone (LH) is still very low. Under 
this condition thecal cells express androgens that are metabolized by the granulosa cells 47. 
The resulting estrogen is then secreted into the blood and initiates endometrium proliferation 
in the uterus. In response to increasing blood estrogen, the anterior lobe of the pituitary gland 
suppresses FSH expression. This triggers the release of LH and thus ovulation. The increase 
in LH again leads to an induction of progesterone and prostaglandins. Progesterone 
stimulates cell proliferation in the uterus, readying the uterus wall, which is called the 
 
Figure 4. Microscopic picture of a 
murine antral follicle showing the thecal 
cell layer (TC), the membrana granulosa 
cell layer (MG), the oocyte (O) with the 
surrounding corona radiata (CR) and the 
cumulus oophorus (CO) (modified from 18). 
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"decidua", for a potential implantation of the embryo. Together with LH, progesterone 
induces the oocyte to complete the first meiotic division. One of the resulting daughter cells 
contains almost no cytoplasm and is called first polar body. The second daughter cell is 
called secondary oocyte, which arrests in the second metaphase (figure 3). The golgi 
apparatus synthesizes small vesicles that accumulate beneath the oocyte cell membrane 
and form the so-called cortical granules 48. A small amount of the cortical granula content is 
already released during oocyte maturation, while the majority is not exocytosed until after 
fertilization 49. Folliculogenesis is now completed and the oocyte will be ovulated. LH induced 
prostaglandins induce the contraction of the ovary. In addition, increased fluid influx from the 
ovary capillaries into the antrum leads to an increasing antral pressure 22. The LH 
furthermore induces the expression of plasminogen activator and collagenase. Collagenase 
is an enzyme that degrades collagen, the main structural protein of mammalian connective 
tissues. Plasminogen is mostly synthesized by the liver with a minor contribution from 
extrahepatic tissues 50. Plasminogen circulates in plasma and most other extracellular fluids, 
such as uterine fluid, ovarian follicular fluid and seminal plasma 51. Trypsin-like plasminogen 
activators exist in oocytes and sperm converting plasminogen into plasmin. Beside a major 
role in fibrinolysis, plasmin can cleave a wide spectrum of proteins. Thus collagenase and 
plasmin lead to degradation of the follicle extracellular matrix. Due to the enzymatic cleavage 
and the increasing antral pressure, the follicle bursts and the oocyte is released into the 
oviduct. Together with the surrounding cumulus cells, the oocyte forms the so-called 
cumulus-oocyte complex (COC). The cells are bonded to each other by extracellular matrix 
comprising proteins and hyaluronic acid 52. The residual follicle cells (membrana granulosa) 
form the corpus luteum, which secretes progesterone, estrogen and inhibin. Inhibin is 
another member of the TGF-β family and inhibits, like estrogen, the expression of FSH and 
thus the maturation of further follicles 53. Progesterone and estrogen lead to an increasing 
proliferation of the uterus endometrium. In rodents the post-ovulatory function of estrogen is 
still discussed, because the estrogen level decreases directly after ovulation. Unlike in 
humans the estrogen level increases with the formation of the corpus luteum and stays 
constant until its degradation at the end of the estrus cycle 54. 
If fertilization fails and no embryo implantation occurs, the corpus luteum is degraded. Thus 
the plasma level of progesterone, estrogen and inhibin decrease again. The FSH expression 
is no longer inhibited and the estrus cycle starts again 55. In humans, the decrease of 
progesterone leads to a shedding of the endometrium and ensuing menstruation. In higher 
mammals including primates, this point in time is commonly defined as the first day of female 
menstrual cycle. Primitive mammals including mice have no menstruation, despite having an 
estrus cycle 20. In humans, the female cycle takes about 28.5 days to complete, and repeats 
until the oocytes pool is depleted 22. Mice as well as some other species show a typical 
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phenomena: the length of the cycle varies, depending on the occurrence of a previous 
mating. If a female mates with a vasectomized, infertile male, the luteal phase (duration from 
ovulation until the beginning of a new cycle) takes about eleven to twelve days. Without 
mating, this phase only takes about two or three days and the corpora lutea synthesize less 
progesterone. This effect is mediated by the mechanical stimulation of the cervix during 
mating. Cervix stimulation further leads to a secretion of prolactin by the anterior lobe of the 
pituitary gland for about ten days and thus to sustained corpora lutea function. If this 
interaction fails because of lack of mating, the cycle is shorter and thus the reproductive 
efficiency is increased 20. 
 
1.2.2 Spermatogenesis in Mammals 
Spermatogenesis can be separated into three phases: proliferation, spermatocytogenesis 
and spermiogenesis (for general overview see figure 3). In humans the complete 
development of the gamete into a mature sperm takes about 65 days, in mice usually 34.5 
days 22,56. Like in females, during embryogenesis the male gametes (spermatogonia) migrate 
to the genital ridge. Next, spermatogonia assemble the primitive sex cord, which persists 
until puberty. Prenatally and leading up to puberty the sex cords acquire cavities eventually 
forming the seminiferous tubules. The epithelia of these cavities differentiate into the Sertoli 
cells, that feed and protect the maturing sperms 22. Gametes and Sertoli cells connect via N-
cadherin molecules on both cell surfaces, and through galactosyltranferase molecules on the 
spermatogonia that bind to carbon hydrate receptors on the Sertoli cells 57,58. Initiation of 
spermatogenesis is likely mediated by BMP8b during puberty 59. At the beginning of the 
spermatocytogenesis, the gametes sequentially differentiate into four A-subtypes (type-A1 to 
A4, see figure 3, summarized as type-A-spermatogonia). These immature spermatogonia are 
located in close proximity to the basal membrane of the seminiferous tubules. Type-A1 
spermatogonia function as stem cells 22. Thus they either replicate into more type-A1 
spermatogonia or they differentiate into type-A2 spermatogonia and later on into type-A3 and 
-A4 spermatogonia. A4 spermatogonia further develop to intermediary spermatogonia. 
Compared to all type-A spermatogonia, intermediary spermatogonia have smaller and more 
compact cell nuclei. After one mitotic division intermediary spermatogonia form two type-B 
spermatogonia that are no longer connected to the basal lamina of the seminiferous tubules. 
All types of spermatogonia undergo incomplete cell divisions, and remain connected to each 
other through thin cytoplasmic bridges 60. Thus the exchange of matter and signals, and thus 
tight coordination of cell divisions is made possible. The type-B spermatogonia perform one 
last mitotic division to build the primary spermatocytes. These bypass the first meiotic cell 
cleavage to form secondary spermatocytes (figure 3). Thereafter the secondary 
spermatocytes undergo meiotic division to form haploid spermatids. Thus four mature sperm 
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cells are formed from one spermatogonium instead of only one oocyte from a female 
oogonium (figure 3). Spermatids are also connected by cytoplasmic bridges so that genetic 
information of one cell can freely diffuse to another cell 61. Thus the spermatids have a 
haploid set of chromosomes, yet still can act like diploid cells. At this stage they gradually 
move into the lumen of the seminiferous tubules, and loose the cell contacts while 
differentiating into spermatozoa. The second stage of the spermatogenesis starts, the 
spermiogenesis. The Golgi apparatus converts into the acrosome. This vesicle contains 
enzymes including hyaluronidase, neuraminidase and acrosin, which are thought to be 
required for penetration of the cumulus cell matrix as well as the ZP 62. The acrosome covers 
the nucleus like a lid. Together they form the sperm head. During differentiation the nucleus 
rotates in a way that the acrosome is directed to the basal membrane of the seminiferous 
tubule. At the opposite side of the nucleus the flagellum is build, starting at the distal 
centriole. Thus the flagellum is oriented towards the lumen of the seminiferous tubule. At the 
end of the spermiogenesis the nucleus condenses, the remaining cytoplasm is pinched off 
and is phagocytized by the surrounding Sertoli cells. The mitochondria build a ring around 
the flagellum. After spermatogenesis, the spermatozoa must undergo further maturation 
steps. First, they are released by the Sertoli cells in a fluid secreted into the lumen of the 
seminiferous tubules 20. Due to this constant fluid flow, the sperm reach the efferent ducts, 
where about 90% of the fluid is resorbed. In the proximate epididymis the fluid resorption is 
continued, so that the sperms become more concentrated. Furthermore the epididymis 
secrets nutrients and stimulants including fructose and glycoproteins that prepare sperm for 
the swimming required for oocyte fertilization 20. The cauda epididymis can store sperm for 
several weeks in mice, and for several day in humans. Finally, sperm reach the seminal duct 
(also called ductus deferens or vas deferens), where they are stored until ejaculation. 
Without copulation and ejaculation, sperm are slowly released into the ureter, and then 
flushed out by urine. 
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1.3 The Zona Pellucida During Folliculogenesis, Fertilization and 
Embryogenesis 
1.3.1 Zona Pellucida Structure 
The zona pellucida (ZP) describes a glycoprotein matrix that surrounds human as well as 
other mammalian oocytes 63. Murine ZP is composed of three sulfated glycoproteins: ZP1 
(200 kDa), ZP2 (120 kDa) and ZP3 (83 kDa) 64. Human ZP have one additional protein, ZP4 
65. The ZP of one murine oocyte contains approximately 5 ng protein, with ZP1-3 comprising 
at least 95% of the total ZP protein amount 66. ZP proteins are exclusively expressed in the 
growing oocyte and are exocytosed. Several studies showed that the molecular ratio of 
ZP1:ZP2:ZP3 is about 1:4:4 67. In mice, ZP2 and ZP3 build filaments that are linked by 
homodimers of ZP1 68. How the three-dimensional meshwork of the ZP is achieved in detail 
is still discussed 69. The ZP first appears as individual islands of ZP material in the space 
between the oocyte and the surrounding granulosa cells and increases in thickness to about 
7 µm in mature mouse oocytes and about 14 µm in human oocytes 70,71. 
Genetic studies in mice revealed that a functional ZP is critical for follicular development, 
fertilization, and for the protection of the pre-implantation embryo. Mice that are deficient in 
ZP1 (Zp1-/-) have oocytes with a thinner, more fragile ZP compared to the wildtype 72. The 
filaments made of ZP2 and ZP3 are much looser, while sperm is still able to bind to and 
fertilize these oocytes. Lack of Zp1-/- leads to morphologically abnormal ZP and female 
subfertility. Amino acid alignment indicates 68% sequence identity of murine and human 
ZP1, and 77% sequence similarity (supplemental figure S1). In humans one of four mutations 
in the ZP1 gene was associated with decreased fertilization success in vitro 73. Compared to 
Zp1 deficiency, lack of Zp2 or Zp3 in mice was associated with a much more drastic 
phenotype 74,75. Both transgenic mouse lines have defects in oocyte maturation and 
decreased numbers of ovulated oocytes, indicating the need of a ZP during follicle 
development. While Zp2-/- oocytes form a thin ZP in early follicles, the ZP is completely 
absent in Zp3-/- eggs. Both deficiencies lead to infertility. Oocytes could be fertilized in vitro, 
but did not lead to pregnancy after transfer into foster mothers. This finding illustrates the 
importance of a functioning ZP in embryo development. Multiple alignment indicates 58% 
sequence identity of murine and human ZP2 and 72% sequence similarity (supplemental 
figure S2). The alignment of murine and human Zp3 shows 68% identical and 77% similar 
amino acids (supplemental figure S3). In humans four mutations are known in the ZP2 gene 
and eight mutations in the ZP3 gene 73. There is no known association of ZP2 mutations and 
the female infertility, while two of the ZP3 mutations are more frequent in the infertile 
females. Zp4 is a pseudogene in mouse, while human ZP4 is expressed and has four known 
mutations, none of which are associated with infertility (supplemental figure S4) 65,73. The 
function of the human ZP4 is thus unknown. ZP4 it is present in levels comparable to ZP2 
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and ZP3 (with ZP1 being a minor component in human oocytes), and therefore is assumed 
to have a structural role 76. 
 
1.3.2 Fertilization 
After ovulation the cumulus-oocyte complex (COC) is transported into the oviduct by the 
fimbriated infundibulum 20. Due to a combination of ciliary motion and oviductal muscle 
contraction, the COC reaches the ampulla, where the fertilization takes place 77. 
During copulation sperm are mixed with seminal fluid an alkaline fluid secreted by the 
seminal vesicle, the bulbourethral gland, and the prostate gland 20. The seminal fluid 
comprises buffer substances, neutralizing the acidic milieu of the vagina, energy-rich 
metabolites including fructose and sorbitol, reducing agents like ascorbic acid that protect 
sperm from oxidation by the atmospheric oxygen, as well as prostaglandins that are thought 
to stimulate uterus muscle activity. During copulation, smooth muscles of prostate, seminal 
vesicle, seminal duct and ureter contract to ejaculate the semen. Unlike humans, male mice 
form a massive secretion that is released into the vulva after the seminal fluid, and hardens, 
preventing further copulation. This so-called "vaginal plug" is visible for 8 to 24 hours 78. 
Following copulation and ejaculation, sperm must migrate through the female genital tract to 
reach the oocyte. Transport through the uterus is mainly mediated by muscle contraction 77. 
After entering the oviduct, sperm becomes hyperactive, an activation step mediated by 
sperm-specific calcium channels located in the sperm tail 79. The movements of the flagellum 
intensify and become more symmetric. Furthermore, the sperm is directed by a temperature 
gradient (thermotaxis) between the different parts of the oviduct as well as chemical 
gradients (chemotaxis) released by the COC in the ampulla 77,80. While the sperm migrate 
through the female genital tract, they undergo further modifications in preparation of 
fertilization proper. This process is called capacitation. It starts with a removal of steroids and 
non-covalently bound glycoproteins from the sperm head membrane, thought to be mediated 
by albumin that is present in the cervix secretion 81. These modifications lead to several 
effects. First, the removal of steroids increases calcium permeability. The calcium influx 
results in the cytoplasmatic release of cyclic adenosine monophosphate (cAMP), facilitating 
sperm-oocyte fusion 82,83. Second, the sperm membrane becomes more fluid. Lipid rafts 
enriched in receptors necessary for sperm-oocyte interaction form at the anterior sperm head 
84. The removal of glycoproteins furthermore unmasks structures that are important for 
sperm-oocyte identification 85. Without capacitation, sperm are incapable of chemotaxis as 
well as of cumulus cell matrix penetration 86,87. Delayed capacitation also has positive effects. 
Incapacitated sperm stick to the oviductal epithelium and keep inactivated until they are 
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capacitated 88,89. This increases sperm lifespan, prevents polyspermy and allows fertilization 
despite possibly delayed ovulation 77,90. 
Due to hyperactivation and membrane hyaluronidase activity, sperm penetrate the cumulus 
cell matrix and reach the oocyte 91,92. Prior to gamete fusion, sperm bind to and penetrate the 
ZP (figure 5) 93. For sperm-ZP interaction several models are discussed 94. It was long 
believed that sperm bind to carbohydrate chains of ZP3 95, because enzymatic 
deglycosylation abrogated sperm binding. Furthermore, the sperm-ZP3 binding was thought 
to trigger the acrosome reaction, a calcium mediated fusion of sperm membrane and outer 
acrosome membrane, which in turn leads to a secondary binding of the sperm to ZP2. Next, 
the released acrosomal enzymes locally digest the ZP and thus make it penetrable for sperm 
85,96. Several lines of evidence however argue against the sperm-ZP3 binding model. 
Mutations of murine ZP3 gene glycosylation positions did not inhibit sperm-oocyte binding 97. 
Using transgenic mouse models and gain-of-function assays, it was instead demonstrated 
that ZP2 is the sperm-ZP ligand in mice and humans 98,99. Furthermore it was shown, that the 
acrosome reaction is not necessary to penetrate ZP 100. 
After penetrating the ZP, the sperm passes the perivitelline space and binds to the plasma 
membrane of the oocyte, the oolemma. The detailed molecular mechanisms of sperm-oocyte 
binding and fusion are not completely understood, but several membrane proteins were 
shown to be important. The integrin CD9 is distributed almost over the entire oocyte surface 
101,102. It is thought that CD9 binds fertilin, an ADAM (a disintegrin and a metalloprotease 
domain) family member at the sperm surface 103. Studies with knockout mice did not identify 
single, indispensible docking molecule. Sperm-oocyte interaction rather seems more to be 
mediated by a multi-protein complex 104. 
Fertilization triggers the influx of calcium into the oocyte cytoplasm and several further 
calcium waves. In non-mammals this leads to membrane depolarization and the so-called 
fast membrane block to polyspermy, occurring 30-60 seconds after fertilization e.g. in sea 
urchin 105. Thus only one sperm can fuse with one oocyte and the zygote stays viable. Similar 
calcium induced changes in the membrane potential were not observed in mouse, hamster 
or rabbit oocytes, indicating that mammalian membrane block is not mediated by membrane 
depolarization 106,107. Additionally, the membrane block in mammals takes about 30-60 
minutes to fully develop, and thus is much more slowly than in non-mammals. The sperm 
induced calcium oscillation furthermore leads to the exocytosis and degranulation of cortical 
granula 108,109, a process summarized as cortical reaction (figure 5). About 100 pg total 
protein containing several proteases are released into the area between the oocyte and the 
ZP, the perivitelline space 69,110. ZP2 (120 kDa) is proteolytically cleaved into ZP2f (90 kDa) 
and a smaller fragment (30 kDa), which remains connected via a disulfide bond 111. The ZP2 
cleavage induces rapid changes in the ZP, which transforms into a physical barrier that 
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prevents further sperm from 
binding 63,93. This second 
block to polyspermy is called 
slow block, indicating the 
delay after fertilization in non-
mammals 105. In mammals, 
the ZP modification is 
established in approximately 
the same time frame as the 
membrane block 107. Thus in 
mammals the two blocks to polyspermy are distinguished spatially (membrane and ZP), but 
not temporally (fast and slow) like in sea urchin. The ZP modification in mammals is called 
ZP hardening, conferring resistance to proteolytic digestion, and mechanical stiffening 112,113. 
Furthermore, the permeability of the ZP decreases in that molecules from about 150 kDa can 
diffuse into pre- and post-ovulatory oocytes, but only molecules of around 110 kDa can 
diffuse into zygotes 39. 
Several factors were thought to mediate ZP hardening. Ovoperoxidase was shown to be 
secreted from mouse oocytes after activation resulting in decreased ZP solubility 114. Cortical 
granula located N-acetylglucosaminidase is exocytosed after fertilization, inactivates specific 
ZP3 oligosaccharides and thus was thought to block sperm binding 115. In sows and heifer, 
the ZP hardening is also promoted by factors of the oviductal fluid. A complex of oviduct-
specific glycoprotein (OGP) and heparin has been shown to increase ZP resistance to 
enzyme digestion 116. In mouse however, oviduct-specific glycoprotein is not associated with 
ZP hardening 117. The role of the plasminogen/plasmin system in reproduction is 
controversial. As already mentioned before, plasminogen activator converts blood serum 
plasminogen into the active enzyme plasmin that also degrades several proteins like fibrin 
clots. Huarte et al. showed that plasminogen is present in the fertilization environment of 
mice 51 and this was also confirmed in pigs and cows 118. Both murine gametes express 
plasminogen activators, but in the oocyte these are located close to the membrane instead of 
in the cortical granules, as expected. Plasmin activity was shown to increase ZP hardening in 
rat while the addition of plasminogen increased sperm binding in mice, pigs and cows 
51,118,119. However, plasminogen deficiency caused no reproductive defects and mice deficient 
for plasminogen activators only showed slightly reduced fertility, most likely due to general 
thrombosis 120,121. Thus the role of the plasminogen / plasminogen activator / plasmin system 
in fertilization seems to be species specific and is still controversial. To our knowledge 
notably none of the above factors is reported to interact with ZP2 processing. The cleavage 
of ZP2 is however, regarded critical in ZP hardening. 
 
Figure 5. Illustration of the mechanism between fertilization and 
polyspermy block. Fertilization induces cortical granula release 
leading to ZP hardening and thus to a block of further sperm binding. 
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The metalloprotease 
ovastacin is the only known 
proteinase, which cleaves 
ZP2, and is expressed 
exclusively in the cortical 
granules 122. In ovastacin 
deficiency (Astl-/-), ZP2 is not 
cleaved after fertilization 
(figure 6). It was anticipated 
that the lack of ZP hardening 
should be associated with 
polyspermy resulting in 
reduced zygote viability. Ovastacin deficient female mice were indeed subfertile, showing a 
reduced mean litter size (5.5 offspring/litter compared to 6.5 of the wildtype). In humans 
polyploidy has been detected in approximately 10-20% of spontaneously aborts and the 
majority of triploid human embryos are the result of polyspermic fertilization 123,124. Amino 
acid alignment indicates 67% sequence identity of murine and human ovastacin gene and 
75% sequence similarity (supplemental figure S5). Thus the ASTL gene is well conserved in 
humans. The thousand genome project lists more than 760 variations in the human ASTL 
gene with 73 sequence variants, that change one or more bases, resulting in a different 
amino acid sequence but with preserved length 
(http://browser.1000genomes.org/Homo_sapiens/Gene/Variation_Gene/Table?db=core;g=E
NSG00000188886;r=2:96789589-96804175). It is currently unknown, whether any of these 
variations further are associated with reduced fertility and pregnancy loss 122,125. 
 
1.3.3 Embryogenesis and Implantation 
Until fertilization the oocyte arrests at the second meiosis. The arrest is mediated by a 
complex of maturation promoting factor (MPF) and cytostatic factor (CSF) 20. After sperm-
oocyte fusion, the calcium influx results in the breakdown of the MPF / CSF complex 77. The 
meiosis of the oocyte is completed and the second polar body appears. In some species 
including humans, the first polar body divides synchronously, giving rise to three polar 
bodies. The sperm including the sperm tail fuse with the oocyte and deliver two centrosomes 
that form the mitotic spindle for cell division. The two cell nuclei do not fuse immediately. 
Instead two pronuclei appear where the male and the female gamete-derived new DNA 
strands are synthesized. Subsequently the nuclear membranes dissolve and the 
chromosomes align in one metaphase plane shortly before the first mitotic division starts. 
Thus diploid cell nuclei first exist in the two daughter cells of the two-cell embryo. Further 
 
Figure 6. Illustration of the absent ZP hardening under ovastacin 
deficiency. Ovastacin deficient oocytes undergo fertilization and 
cortical granula reaction but lack ZP hardening, eventually leading to 
polyspermy and thus to a decreased mean litter size compared to 
wildtypes. 
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segmentations lead to a progressive reduction of the cell volume and the maintenance of the 
embryo volume. Around the 16- to 32- cell stage, the morula with the blastocoel is formed 
(compaction) and afterwards the blastula forms (cavitation), separating the inner cell mass 
(ICM) from the trophectoderm (TE). In mice, the development from zygote to blastula takes 
about 3.5 - 4 days, and in humans 4 - 6 days, respectively 126. During early development, the 
embryo is surrounded by the ZP and is transported from the oviduct to the uterus where it 
implants at the blastula stage. Premature ZP release leads to a resorption of the developing 
embryo by the oviductal epithelium and thus to a reduced fecundity, e.g. in the Zp1-/- mice 72. 
These results illustrate that the ZP is required for proper oocyte development, species-
specific fertilization, polyspermy block, and for the protection of the pre-implantation embryo 
until it reaches the uterus. The release of the blastocyst from the ZP is called ZP hatching or 
blastocyst hatching. ZP hatching is thought to be mediated by three different processes: 1) 
several autocrine and paracrine molecules, 2) dynamic cellular components and 3) 
hydrostatic pressure 127. ZP hatching starts with a nick in the ZP, caused by local enzymatic 
digestion. Several autocrine and paracrine molecules expressed by the blastocyst or by the 
endometrium including growth factors, cytokines and proteases promote ZP hatching 127. In 
mice the embryonic tryptase strypsin (encoded by the implantation serine proteinase 1 (Isp1) 
gene) is essential in ZP hatching 128,129. ISP1 as well as the strypsin-related proteinase ISP2 
are expressed in the endometrium during implantation, and are regulated by progesterone 
130,131. Dynamic cellular components including actin-based trophectodermal projections 
(TEPs) penetrate the ZP and promote ZP hatching by undulating movements 132. The 
existence of these TEPs was demonstrated for hamster, bovine, equine, monkey, human 
and guinea pig, but not for mice 132–134. ZP hatching is promoted by undulating contraction 
and expansion of the blastocyst. The hydrostatic (mechanical) pressure results in thinning of 
the ZP. Thus the blastocyst gradually escapes the ZP, which remains largely intact as a 
ghost 135,136.  
If ZP hatching fails, embryonic development stops, resulting in miscarriage. Thus several 
methods were developed to assist ZP hatching and improve implantation 137,138. For assisted 
hatching the ZP is either partial dissected, locally dissolved by the use of acids or perforated 
by local laser exposure. Although these methods increase the incidence of implantation per 
embryo replaced, they are still suspected to cause damages to individual blastocyst with 
decreasing embryo development 139,140. In addition, ZP laser perforation has been associated 
with an increased risk of monozygotic twinning 141. 
After ZP hatching, the trophectoderm secretes (human) chorionic gonadotropin (hCG) to 
obtain the corpus luteum. The progesterone level stays constant and thus the shedding of 
the endometrium and a miscarriage is prevented. A multitude of growth factors, hormones 
and other substrates are expressed by the embryo and the endometrium of the uterus as the 
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embryo becomes competent for implantation 142. Trophoblast-derived cellular protrusions 
extend into the endometrium and adhere to epithelial cells by microvilli 127. Contraction of the 
trophoblast microfilaments allows the blastocyst to invade between the endometrial cells. 
Invasion continues until the embryo finds a uterine spiral artery that will provide the embryo 
with nutrients during the further development 143. After implantation, the trophectoderm 
sustains hCG expression 55.  HCG level reaches a peak at the end of the first trimester of the 
gestation period, which is exploited in the majority of pregnancy tests. Placentation occurs 
and is followed by further embryogenesis and fetal development until birth. In humans the 
development from fertilization to birth takes about 40 weeks, and in mice 18-20 days, 
respectively 78. 
 
1.3.4 Premature ZP hardening 
Cortical granula release does not only occur after fertilization, but also at a low level before 
fertilization during meiotic maturation and ovulation 49,144. In mice, germinal vesicle intact 
oocytes have about 5400 cortical granules, of which about 1300 are released during 
germinal vesicle breakdown 49. During in vitro fertilization the spontaneous cortical granula 
release induces premature ZP hardening (figure 7) resulting in a decreased fertilization 
success 71,145. In vivo, partial degranulation however, does not normally trigger ZP hardening 
indicating that there must be an inhibitor of ZP hardening. Cortical granule loss increases 
drastically in vivo about 30 hours after ovulation and is finished about 15 hours later 146. Thus 
in vivo, spontaneous ZP hardening starts simultaneously to cortical granule loss, indicating 
that the inhibitor capacity is overcome. ZP hardening constantly increases for further 60 
hours. Fertilization success 
decreases starting directly 
after ovulation (from 95% to 
80%). About 42 hours after 
ovulation the fertilization 
success in vivo drops 
precipitously, from 80% to 0% 
within two hours, indicating 
that partial ZP hardening is 
sufficient to prevent 
fertilization.  
In vitro spontaneous ZP hardening is much faster. A reduction in fertilization can already be 
seen after 15 minutes 147. In vitro spontaneous ZP hardening can be prevented by adding 
serum, especially fetal calf serum (FCS), human serum or human follicular fluid to IVF 
 
Figure 7. Illustration of the mechanism between spontaneous 
cortical granula reaction and premature ZP hardening. 
Spontaneous cortical granula release during oocyte maturation results 
in premature ZP hardening and thus decreases fertilization success in 
vitro. 
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medium, collectively suggesting that both follicular fluid and serum contain factors that inhibit 
premature ZP hardening 147,148. One challenging task in formulating cell culture media for IVF 
is safety and the exclusion of protein or virus transmitted disease 149. In the last decades 
either human serum with its undefined composition or the more defined purified human 
serum albumin was mostly used in IVF media. Reports of notorious lot-to-lot variability in 
human serum and human serum albumin have been blamed for fluctuating pregnancy 
success in clinics. Furthermore, even after heat inactivation and filtration, human serum still 
carries the risk of contamination with infectious disease such as human immunodeficiency 
virus (HIV) or hepatitis 150. Pathogenic proteins like prions that may cause Creutzfeldt-Jakob 
Disease are likewise a serious concern 151. Thus it was a purpose to replace serum by a 
defined and safe recombinant protein source. Early on, purified or recombinant human serum 
albumin alone were found insufficient to prevent premature ZP hardening 149,152. Beside FCS 
and human follicular fluid, the presence of an intact cumulus oophorus decreased premature 
ZP hardening and increased fertilization success, although less efficient than the addition of 
serum 147,153. These findings support the idea that the extracellular matrix of the cumulus 
cells stores serum-derived factors that contact the COC during folliculogenesis, especially at 
antrum formation. Several studies suggested that fetuin-A (originally designated fetuin) was 
involved in the prevention of ZP hardening 148,152,154–156. Kalab and colleagues showed in 
1991 that the use of bovine fetuin during IVF decreased ZP hardening, and increased 
fertilization success 154. Two years later it was demonstrated that fetuin-A is present in 
human follicular fluid, but that the inhibitory effect of follicular fluid to ZP hardening still 
existed after immunodepletion by fetuin-A antibodies of the follicular fluid 148. The authors 
concluded that there should be inhibitory molecules other than fetuin present in follicular fluid 
that prevent premature ZP hardening. Recently it was shown that serum fetuin-A increased 
in patients undergoing IVF, but this increase did not correlate with fertilization success 157. 
Additionally, fetuin-A deficient mice are fully fertile, arguing against a role for fetuin-A in 
fertilization 7,8,158. Considering that fetuin-B was not known at the time of the earlier studies 
and that fetuin-B deficient female mice showed blocked fertilization, we hypothesized that 
fetuin-B could be involved in the prevention of ZP hardening 17.  
The fact that fetuin-B could still be extracted from most tissues even after tissue perfusion 
suggested, that fetuin-B tightly associates with the extracellular matrix 2. In addition it was 
shown that maintaining the cumulus mass during in vitro maturation decreased premature ZP 
hardening 147. Thus we hypothesized that fetuin-B diffuses from the blood into the follicular 
fluid, where it surrounds the oocytes during maturation (figure 8). After ovulation, the 
surrounding cumulus cells and their extracellular matrix could work as storage of fetuin-B 
until fertilization to avoid premature ZP hardening in vivo. After fertilization, ovastacin is 
released from the cortical granula, suddenly increasing the amount of ovastacin around the 
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oocyte. Concomitantly the 
amount of surrounding fetuin-
B probably decreases due to 
sperm-mediated cumulus cell 
matrix degradation. Thus 
ovastacin concentration would 
exceed inhibition capacity of 
fetuin-B, leading to 
fertilization-triggered ZP 
hardening. 
 
 
 
 
 
1.4 The Mouse as Model Organism 
In mammalian studies the house mouse (Mus musculus) has often become the animal of 
choice. Mice in general have a small size compared to other mammals. This reduces the 
space necessary for animal husbandry. Mice furthermore show rapid generation times and 
large litter size. One mouse year equals about thirty human years, minimizing time required 
to perform research. In 1909 C. C. Little developed the first inbred mouse strain named DBA. 
One of the most popular mouse strains, C57BL/6 was likewise bred by Little in the year 
1921. In the year 1982 the group of Palmiter and Brinster developed methods to insert 
foreign DNA into the germ line of mice. Between 1987-1989 Evans, Smithies and Capecchi 
created the first knockout mice, breaking new ground in genetic research. 
In 2001 the first human genome was assembled and published by Venter and colleagues 159. 
The first mouse genome was published in 2002 and was reported about 14% smaller than 
the human genome 160. At the nucleotide level 40% of the human and mouse genome can be 
aligned. Approximately 99% of mouse genes have a homologue in the human genome, 
allowing the transfer of murine genetics to humans. DNA sequence comparisons between 
their consensus sequence and publicly funded genome data provided locations of 2.1 million 
single-nucleotide polymorphisms (SNPs) in the human genome and about 0.8 million in mice. 
Less than 1% of all SNPs resulted in variation in proteins, but the functional consequences of 
most of these SNPs are still unknown. To study human genomic mutations and their 
associated phenotypes, model organisms are required. Transgenic mice nowadays serve as 
 
Figure 8. Illustration of the hypothesized function of fetuin-B. At 
spontaneous cortical granula release fetuin-B inhibits ovastacin activity 
and thus premature ZP hardening to maintain fertility (left). After 
fertilization the enhanced release of ovastacin overcomes the 
inhibitory capacity of fetuin-B, leading to ZP hardening and blocked 
polyspermy (right). 
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a very potent model to study the correlation between genetic defects and diseases as well as 
the adequate medication.  
Reproductive biology, including gametogenesis, fertilization and embryogenesis is largely 
conserved in mammals, and most loss-of-function mutations have been determined using 
mice 161,162. Beside small differences, for example the ZP composition (in humans ZP1-4, in 
mice ZP1-3), the mouse is a potential model organism to study mammalian and especially 
human reproduction biology. 
Using mice as a model organism the choice of the strain background can have a dramatic 
effect on the phenotype 8. To avoid background specific effects, fetuin-B deficient mice were 
studied in two different mouse strains (C57BL/6 and DBA/2). A facts sheet of basic and 
reproductive parameters of C57BL/6 and DBA/2 mice is shown in table 2. DBA/2 mice show 
a shorter lifespan than C57BL/6. While the DBA/2 females are generally heavier than 
C57BL/6 females of similar age, the males show the opposite effect. Although C57BL/6 
females yield lower numbers of oocytes after superovulation and have lower fertilization 
success after IVF they produce a higher number of pubs per litter. 
 
Table 2. Vital and reproductive statistics of C57BL/6J and DBA/2J mice. 163–166 
 C57BL/6J mice DBA/2J mice 
Lifespan (days) female / male 856 / 894 580 / 641 
Body weight (g) female / male 
 
2 month: 17.7 / 22.2 
6 month: 23.5 / 30.7 
12 month: 26.0 / 35.5 
20 month: 24.1 / 32.6 
2 month: 18.9 / 21.5 
6 month: 29.9 / 29.5 
12 month: 27.2 / 27.5 
20 month: 25.7 / 21.8 
Age at vaginal opening (patency) (days) 34.3  37.7 
Gestation duration (days) 19.17 19.71 
Number of pubs / litter 7.67 163 
6.60 164 
5.89 165 
5.73 163 
5.00 164 
4.85 165 
Interval between litters (days) 37.3 29.1 
Females responding to superovulation (%) 100 95 
Oocytes per donor after superovulation / live 
oocytes (%) 
25.2 / 98.7 34.2 / 98.5% 
Fertilization success after IVF (% of 2-cell embryos) 66.2 93.5 
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1.5 Aim of the Study 
At the beginning of this study it was known that fetuin-B deficient females are infertile 
because of a fertilization blockade 18. I had already demonstrated that fetuin-B deficient 
oocytes can be fertilized after physically overcoming the ZP by laser perforation, and that the 
infertility of Fetub-/- females is caused by a defect in the ZP 19. 
The aim of the dissertation was to examine if premature ZP hardening caused the female 
infertility of fetuin-B deficient mice. Furthermore, I investigated if fetuin-B is able to inhibit ZP 
hardening (by inhibiting ovastacin protease) and if the supplementation of fetuin-B during IVF 
can increase the fertilization success. 
- Experimental Procedures - 
27 
2. Experimental Procedures 
 
The animal welfare committee of the Landesamt für Natur-, Umwelt- und Verbraucherschutz 
(LANUV) of the state of North Rhine Westfalia approved our animal study protocol. Animal 
maintenance, handling and anesthesia were performed according to the Federation for 
Laboratory Animal Science Associations FELASA recommendations in the animal facility of 
the University Hospital Aachen. Animals were sacrificed by isoflurane overdosing. 
Laser-assisted in vitro fertilization (LA-IVF) and embryo transfer was performed in 
collaboration with Tanja Pfeffer and professor René Tolba, Institute for Laboratory Animal 
Science RWTH Aachen University.  
The fetuin-A and fetuin-B producing adenoviruses was recombined and cells were infected 
by the adenovirus in the S2 laboratory of professor Ralf Weiskirchen, Institute Molecular 
Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry, RWTH Aachen 
University.  
Expression of recombinant ovastacin as well as fetuin-B ovastacin inhibition assay was 
performed in cooperation with professor Walter Stöcker, Institute of Zoology, Cell and Matrix 
Biology, Johannes Gutenberg University Mainz. 
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2.1 Fertility Evaluation of Fetuin-B Deficient Mice 
2.1.1 Mouse Genotyping 
For genotyping tail biopsies of about 1-2 mm length were taken from four week old mice. The 
tissue was digested in 500 µl buffer (100 mM TRIS/HCl, pH 8.5, 5 mM EDTA, 0.2% SDS, 
200 mM NaCl) each, containing 0.18 U/µl recombinant Proteinase K (Thermo Scientific 
#EO0492, PCR grade), over night at 55 °C. DNA was precipitated by isopropyl alcohol 167 
and again dissolved in 80 µl TE buffer (10 mM TRIS/HCl, pH 8.0, 1 mM EDTA). Genotyping 
was performed by multiplex-PCR, see tables 3 and 4. For amplification DreamTaq™ Green 
DNA Polymerase system (Thermo Scientific #EP0713) was used as well as the following 
primers:  P4as  5’-GCT TGA ACG ATG GGA TAG GC-3’, P6s  5’-CAA GTT CTA ATT CCA 
TCA GAA GC-3’ and P8s  5’-GGG CCT GCT CAG TGT CTA CC-3’. 
 
When separated on 1% agarose gel, amplicon signifying fetuin-B deficiency showed a size of 
about 600 bp as expected, while the wildtype-specific amplicon showed the expected size of 
1100 bp. 
 
2.1.2 Breeding Performance 
Females were mated at 10 - 25 weeks of age with 12 - 20 week old males of the identical 
genetic background (C57BL/6 or DBA/2). Copulation success was scored by the presence of 
a vaginal plug. Two weeks after copulation females were examined for pregnancy and after 
delivery the litter size was documented. 
 
2.1.3 Fetuin-B Western Blot  (Murine and Human) 
Fetuin-B serum concentration in fetuin-B heterozygous and wildtype mice was measured by 
quantitative Western blot. Recombinant murine fetuin-B (Invigate, Lot. C110113-02) with a 
known concentration was used for calibration. Six different concentrations were loaded from 
0 to 35 ng/lane. Serum samples were diluted 1:100 in sample buffer (0.125 M TRIS/HCl, pH 
Table 3. Mastermix for fetuin-B genotyping. 
 
component end concentration 
buffer (10x) 1x 
dNTPs 0.2 nmol/µl 
betain 1.0 µmol/µl 
P4as 1.2 pmol/µl 
P6s 0.8 pmol/µl 
P8s 1.2 pmol/µl 
Taq polymerase 0.025 U/µl 
pure water up to 23.5 µl 
genomic DNA 1.5 µl 
 
Table 4. PCR program for fetuin-B genotyping 
by using a T3 Thermocycler (Biometra). 
 
temperature time cycles 
94 °C 1 min  
94 °C 20 sec  
56 °C 30 sec 35 x 
71 °C 2 min  
71 °C 7 min  
4 °C ∞  
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6.8, 5% SDS, 10% glycerol, 10% beta-mercaptoethanol, 0.01% bromophenole blue) and 
were heated up for five minutes at 95 °C 168. Fifteen µl  of each sample were loaded onto a 
10% polyacrylamide SDS-PAGE using the Biorad mini gel system. Proteins were “semi-dry” 
blotted on a nitrocellulose membrane (Whatman #10439396) with 1.5 mA/cm2 for one hour. 
Successful protein transfer was evaluated by Ponceau-S staining (0.2% Ponceau-S red in 
5% acetic acid). The blotting membrane was blocked overnight using 5% non-fat dry milk 
powder in PBST (phosphate buffered saline supplemented with 0.05% Tween®20) at 4 °C. 
Polyclonal rabbit anti-mouse fetuin-B (K320, bleeding 28.09.2000) was diluted 1:1000 in 
blocking buffer and incubated with the membrane for one hour at 37 °C in a rotating 50 ml 
reaction tube. Afterwards the membrane was washed three times with PBST at 37 °C for five 
minutes each. Polyclonal swine anti-rabbit IgG/HRP (Dako #P0217) was diluted 1:5000 in 
blocking solution and incubated for one hour at 37 °C. Afterwards the membrane was 
washed three times with PBST at 37 °C for five minutes each. Chemiluminescence signal 
was developed using ECL-substrate (1.25 mM 3-Aminopthalhydrazide, 0.45 mM p-Coumaric 
acid, 0.015% hydrogen peroxide). Luminescence was detected using a LAS4000-mini 
imaging system (Fuji). Quantification was performed using the software ImageJ. 
The Western blot measuring human fetuin-B was done like described above for mouse. Anti-
human fetuin-B antibody was used to detect bovine as well as human fetuin-B. Commercial 
bovine fetuin preparations (7.5 µg per lane) from various sources were separated by SDS-
PAGE (10% acrylamide): Sigma-Aldrich F2379 (bov fetuin1), Sigma-Aldrich F3004 (bov 
fetuin2), Sigma-Aldrich F2379 (bov fetuin3) and further purified by gel filtration, AppliChem 
A2783 (bov fetuin4). Blocking was mediated by 1% bovine serum albumin (BSA) in PBST. 
Primary antiserum polyclonal rabbit anti-human fetuin-B (K316, bleeding 04.04.2001) was 
diluted 1:1000 and polyclonal swine anti-rabbit IgG/HRP (Dako #P0217) as secondary 
antibody was diluted 1:2000. 
 
2.1.4 Collection of Zygotes and Oocytes 
To confirm blocked fertilization in fetuin-B deficient oocytes potential zygotes were isolated 
after spontaneous mating. The zygotes and unfertilized oocytes were isolated from the 
ampulla and were liberated from surrounding cumulus cells by digestions in 300 µl human 
tubular fluid (HTF, for detailed chemical composition see table 5) medium containing 0.3 
mg/ml hyaluronidase (22.5 – 45 IU/ml, Sigma) for 2-3 minutes. Afterwards oocytes and 
zygotes were washed five times in 50 µl HTF medium each, to get rid of the cumulus cells. A 
comprehensive protocol is found in “Manipulating the mouse embryo” 169. Subsequently 
potential zygotes were scored microscopically for signs of fertilization like an enlarged 
perivitelline space and the existence of two polar bodies. 
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For further oocyte analysis follicular growth of 
five to ten week old mice was stimulated by 
injection of five international units (IU) pregnant 
mare serum gonadotropin (PMSG, Intervet 
#A034A02, stock 500 IU/ml, diluted 1:10 in PBS, 
100 µl/mouse injected). For the collection of pre-
ovulatory oocytes, the mice were sacrificed. 
Using a stereo microscope and a micropipette, 
antral follicles were punctured to recover 
oocytes. For the collection of post-ovulatory 
oocytes, five IU human chorionic gonadotropin 
(hCG, Intervet #A034A01, stock 500 IU/ml, 
diluted 1:10 in PBS, 100 µl/mouse injected) were 
injected 48 hours post-PMSG to stimulate 
ovulation. 13 hours post-hCG the female mice 
were sacrificed by cervical dislocation. Oocytes 
were collected as described above. All incubations were done at 37 °C in gassed (5% CO2, 
5% O2, 90% N2) medium covered with mineral oil, pre-incubated over night. 
 
2.1.5 In Vitro Fertilization and Embryo Transfer 
Oocytes were collected after hormonal stimulation 
with PMSG and hCG (superovulation) as described 
in the paragraph 2.1.4 "Collection of Zygotes and 
Oocytes" without hyaluronidase treatment. Sperm 
was collected from the cauda epididymis and vas 
deferens of 14 - 16 week old males in TYH+MBCD 
medium (for chemical composition see table 6) and 
incubated for 60 minutes at 37 °C. Sperm was 
counted and a final concentration of 1 - 2.5 x 106 
sperm per ml was mixed with two to five COCs. 
Following four hours of incubation the zygotes were 
washed four times in 150 µl HTF medium each to 
remove excess sperm and any residual debris. 24 
hours later the embryos were evaluated and 
counted. In another group of oocytes the ZP was 
twice perforated using a laser before the addition of sperm. All incubations were done at 37 
°C in gassed (5% CO2, 5% O2, 90% N2) medium covered with mineral oil, pre-incubated over 
Table 5. Chemical composition of human 
tubular fluid (HTF) medium 
chemicals end concentration 
NaCl 5.9 g/L 
KCL 350.0 mg/L 
MgSO4 x 7 H2O 49.0 mg/L 
KH2PO4 54.0 mg/L 
CaCl2 x 2 H2O 755.0 mg/L 
NaHCO3 2.1 g/L 
glucose 500.0 mg/L 
Na-lactate (60% sol.) 3.4 mL/L 
Na-pyruvate 37.0 mg/L 
penicillin G 75.0 mg/L 
streptomycin 50.0 mg/L 
BSA 4.0 g/L 
phenol red (0.5% sol.) 0.4 mL/L 
 
Table 6. Chemical composition of TYH + 
MBCD (methyl-β-cyclodextrin) medium 
chemicals end concentration 
NaCl 6.98 g/L 
KCL 356.0 mg/L 
MgSO4 x 7 H2O 293.0 mg/L 
KH2PO4 162.0 mg/L 
CaCl2 x 2 H2O 251.0 mg/L 
NaHCO3 2.1 g/L 
glucose 1.0 g/L 
Na-pyruvate 55.0 mg/L 
penicillin G 75.0 mg/L 
streptomycin 50.0 mg/L 
MBCD 983.0 mg/L 
polyvinylalcohol 1.0 g/L 
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night. Laser-perforation as well as embryo transfer was performed with Tanja Pfeffer and 
René Tolba, Institute for Laboratory Animal Science RWTH Aachen University. 
For embryo transfer, either wildtype or Fetub-/- females eight weeks of age were mated with 
vasectomized males to induce pseudo pregnancy. About 36 hours post-mating the embryos 
derived from laser-assisted in vitro fertilization were transferred into the pseudo pregnant 
mice following established protocols 169. For the transfer pseudo pregnant mice were 
anaesthetized, the skin was disinfected and a dorsal lateral cut opened the abdomen. 15 
wildtype or Fetub-/- derived embryos were implanted each per mouse. Embryos were 
transferred using a micropipette directly into the infundibulum. To minimize physical strain 
the embryos transfer was done unilateral, meaning that only one of the two oviducts was 
used. After transfer the subcutis was stitched up and epidermis was closed with clips.  
Fetuses were dissected at embryonic day 16 to avoid cannibalism and loss of pups. These 
fetuses were killed and analyzed by histology. Complete fetuses were shock-frozen using 
liquid nitrogen cooled iso-pentane. The tissue was cut into 10 µm sections and fixed with zinc 
fixative (BD Pharmingen™ #550523). Afterwards the sections were washed three times with 
PBS and one time with pure water for five minutes each. Basophilic cell components were 
stained for one minute with hematoxylin (Roth® #T865.1) and staining was differentiated 
under running water for ten minutes. Subsequently acidophilic cell components were stained 
with eosin (Roth® #X883.2) for one minute. Sections were dehydrated using a graded 
ethanol series (70%, 95% and 100%) and three washes with xylene for five minutes each. 
Sections were mounted using Roti®-Histokitt (Roth® #6640) and glass cover slips. 
Microphotographs were recorded using a stereomicroscope (Leica MZ6) and an attached 
digital camera (JVC KY-F75U). 
Alternatively the transferred embryos were carried to full term to study early childhood 
development and maternal care. Following birth the pups were inspected for general health 
every other day until they reached puberty (about four weeks). 
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2.2 Testing for Zona Pellucida Hardening  
 
2.2.1 Oocyte Diameter and Zona Pellucida Thickness 
Oocytes were isolated after hormonal stimulation as described at paragraph 2.1.4 with 
removal of the cumulus cells by hyaluronidase digestion. Two-cell embryos were obtained by 
IVF. Oocyte diameter as well as ZP thickness was measured at three different representative 
positions for each oocyte or embryo using a microscope and DISKUS image acquisition and 
analysis software (Carl Hilgers, Königswinter). Mean values for each cell were blotted at the 
graph. 
 
2.2.2 Zona Pellucida Digestion 
Same oocytes and two-cell embryos that were used for diameter and ZP thickness 
measurements were also used for ZP digestion. The assay was performed like reported 
before using a 0.2 mg/ml chymotrypsin (10 IU/ml) solution 170. Oocytes and embryos were 
washed two times in 100 µl PBS and two times in 100 µl PBS containing 0.2 mg/ml 
chymotrypsin each. Oocytes and embryos were placed in a fresh 100 µl drop of 
chymotrypsin solution and a microscopic picture was taken every minute. The percentage of 
zona free oocytes was plotted against the time. Data were plotted as a sigmoidal time curve 
with variable slope using GraphPad Prism statistics software. T50 the time point at which 
50% of oocytes had become zona free was calculated using a four parameter logistic 
regression. 
 
2.2.3 Sperm Binding 
Oocytes were collected as described in the paragraph 2.1.4 "Collection of Zygotes and 
Oocytes" with hyaluronidase treatment to remove cumulus cells. After washing the oocytes 
they were placed in 500 µl HTF medium. Two-cell embryos were obtained by IVF. Sperm 
was collected and capacitated as described in the paragraph 2.1.5 "In Vitro Fertilization and 
Embryo Transfer". Sperm was counted and a final concentration of 1 x 106 sperm/ml was 
mixed with 30-50 oocytes or 2-cell embryos, respectively. All incubations were done at 37 °C 
in gassed (5% CO2, 5% O2, 90% N2) medium covered with mineral oil, pre-incubated over 
night. After one hour of incubation oocytes were washed up to ten times employing 100 µl 
HTF medium in each washing step to remove all but two to six sperm on normal two-cell 
embryos (negative control). Oocytes were fixed in 2% para-formaldehyde (PFA), and sperm 
binding was quantified by a microscope and DISKUS image acquisition and analysis 
software (Carl Hilgers, Königswinter). 
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2.2.4 ZP2 Western Blot 
20 - 30 oocytes from wildtype and Fetub-/- mice as well as two-cell embryos were isolated as 
described under 2.1.4, dissolved in sample buffer and separated by a 8% polyacrylamide 
SDS-PAGE to detect cleavage of ZP2 as described before 171. Unspecific antibody binding 
was blocked with 5% non-fat dry milk powder in TBST (TRIS buffered saline with 0.05% 
Tween20) for two hours at room temperature. Primary antibody rat anti-mouse ZP2 (M2c.2) 
was diluted 1:500 in blocking solution and incubated over night at 4 °C. Secondary antibody 
goat anti-rat IgG/HRP (Santa Cruz #SC2065) was diluted 1:5000 in blocking solution for one 
hour at room temperature. Chemiluminescence signal was achieved using ECL Plus 
substrate solution (GE Healthcare #RPN2132) and was detected by the LAS4000-mini 
imaging system (Fuji).  
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2.3 Ovastacin Inhibition by Fetuin-B 
 
2.3.1 Recombinant Fetuin-A and Fetuin-B Expression 
This work was performed by Eddy van de Leur and Ralf Weiskirchen, Institute Molecular 
Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry, RWTH Aachen 
University as well as Julia Floehr, Helmholtz-Institute for Biomedical Engineering, 
Biointerface Laboratory, RWTH Aachen University.  
Mouse full-length fetuin-A or fetuin-B cDNA was amplified and ligated into the adenoviral 
shuttle vector pΔE1sp1A and transposed into adenovirus (Ad5) as described 17,172. The 
resulting viruses were used to infect Cos-7 cells. After an overnight incubation period the 
media was changed to a serum-free culture and incubated for another 24 hours to obtain 
serum-free cell culture supernatant containing fetuin-A or fetuin-B. The cell culture 
supernatant was filtered through a 0.45 µm filter and the His-tagged recombinant fetuin-A or 
fetuin-B was purified using HisTrap affinity columns and an ÄKTA liquid chromatography 
system (GE Healthcare). The fractions containing the purified proteins were pooled and 
dialyzed against PBS. Recombinant proteins were identified by Western blot, the purity was 
judged by SDS-PAGE and Coomassie Blue staining. 
 
2.3.2 Ovastacin Expression 
This work was performed by professor Walter Stöcker, Institute of Zoology, Cell and Matrix 
Biology, Johannes Gutenberg University Mainz and coworkers. 
Mouse full-length ovastacin cDNA (Q6HA09) was amplified and transferred into pFastBac1 
(Bac-to-Bac system, Life Technologies, Darmstadt) using the SphI and HindIII sites, verified 
by sequencing (SeqLab, Göttingen) and transposed into baculovirus 17. The resulting 
bacmids were used to infect Sf9 insect cells for virus amplification. Cells and debris were 
removed by centrifugation and the proteins precipitated from the supernatant in 50 mM 
TRIS/HCl, pH 7.4 containing 60% (w/w) ammonium sulfate for 12 hours at 4 °C. Protein 
pellet was obtained by centrifugation (10.000 x g, 2 hours, 4 °C), dissolved in 1/10 volume of 
50 mM TRIS/HCl, pH7.4, 150 mM NaCl, dialyzed vs. the same buffer, loaded onto a strep-
tactin sepharose column (IBA, Göttingen) and the purified ovastacin eluted by adding 2.5 mM 
desthiobiotin (IBA, Göttingen). 
 
2.3.3 Inhibition Assay 
This work was performed by professor Walter Stöcker, Institute of Zoology, Cell and Matrix 
Biology, Johannes Gutenberg University Mainz and coworkers. 
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Ovastacin activity with or without added recombinant fetuin-B was monitored at 37 °C in 50 
mM TRIS/HCl, pH 7.4, 150 mM NaCl using a thermostatted Varioscan fluorescence plate 
reader (Thermo Scientific) in FRET (fluorescence resonance energy transfer) mode, and the 
substrate, Ac-RE(EDANS)-DRnLVGDDPY-K(DABCYL)-NH2 at 10 mM (Biosyntan, Berlin; nL 
= norleucine). IC50 analysis was performed using GRAFIT (Erithacus Software, Wilmington 
House, UK). Initial rates were normalized to complete substrate turnover subsequently 
obtained by proteinase K (Sigma-Aldrich) treatment. 
 
 
2.4 In Vitro Zona Pellucida Hardening Under Fetuin-B Supplementation 
 
2.4.1 Buffer Change for Recombinant Fetuin-B 
Recombinant murine fetuin-B (rmFetuB) was stored in PBS at concentrations of about 3.0 
mg/ml. For in vitro experiments concentrations from 0.015 mg/ml to 1.0 mg/ml were used. 
PBS is thought to induce cortical granula release and thus spontaneous ZP hardening. To 
avoid PBS-induced ZP damages through the use of the rmFetuB a change of buffer was 
necessary. A 2 ml Zeba Desalt Spin Column (Thermo Scientific #89889) was rinsed with 
sterile ultrapure water following the instructions for use. Next, 200 - 700 µl of rmFetuB in PBS 
were loaded onto the column to exchange PBS for water. The flow through (rmFetuB in 
ultrapure water) was stored at 4 °C. The identical column was flushed with sterile HTF 
medium (for detailed composition see 2.1.4 “Collection of Zygotes and Oocytes”) without 
BSA or antibiotics. The rmFetuB in ultrapure water was loaded onto the column equilibrated 
with HTF medium. The flow through of this second gel filtration contained about 2 mg/ml 
rmFetuB in HTF medium without BSA or antibiotics. To add BSA, rmFetuB containing HTF 
medium without BSA and antibiotics was mixed with the same volume of HTF medium 
containing twice the final amount of BSA and antibiotics. The resulting HTF medium 
containing approximately 1 mg/ml rmFetuB, was sterilized using a 0.45 µm filter. HTF 
medium with 1 mg/ml rmFetuB was either used directly or was further diluted to obtain HTF 
medium containing 0.5 mg/ml, 0.25 mg/ml, 0.125 mg/ml, 0.063 mg/ml, 0.031 mg/ml or 0.015 
mg/ml for further use. 
 
2.4.2 Effects of Fetuin-B to Fertilization, Embryo Development and Hatching 
COCs of wildtype females were isolated as described in chapter 2.1.4 without hyaluronidase 
treatment in either HTF medium without fetuin-B or HTF medium containing 1 mg/ml 
rmFetuB. All incubations were done at 37 °C in gassed (5% CO2, 5% O2, 90% N2) medium 
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covered with mineral oil, pre-incubated over night. Collection of sperm and IVF was done as 
described at 2.1.5. Following four hours of incubation the zygotes were washed four times in 
either 100 µl HTF medium without fetuin-B or 100 µl HTF medium containing 1 mg/ml 
rmFetuB each, to remove excess sperm and any residual debris. 24 hours later the embryos 
were evaluated and counted. To test ZP hardening one half of the two-cell embryos were 
used for ZP digestion (see paragraph 2.2.2). For evaluation of developmental potential the 
other half of two-cell embryos were transferred to 100 µl drops of M2 medium (Sigma-Aldrich 
#M7167) covered with mineral oil, pre-incubated over night. Zygotes were evaluated 48 and 
120 hours after fertilization until blastula stage and ZP hatching appeared. 
 
2.4.3 Zona Pellucida Hardening During In Vitro Cultivation 
COCs of three to four wildtype females were isolated in 300 µl HTF medium as described in 
chapter 2.1.4. All incubations were done at 37 °C in gassed (5% CO2, 5% O2, 90% N2) 
medium covered with mineral oil, pre-incubated over night. After hyaluronidase treatment to 
remove cumulus cells the oocytes were washed three times in 150 µl HTF medium each. 
Finally oocytes from up to ten females were pooled in 400 µl HTF medium. From this oocyte 
stock at least 20 oocytes per condition were either directly treated with alpha-chymotrypsin 
as described in chapter 2.2.2 or cultured for 1, 2, 4, 6, 8, 10, 12, 16, 20, 24, 28, 32 or 36 
hours before ZP digestion.  
 
2.4.4 Inhibition of Zona pellucida Hardening After one Hour of In Vitro Cultivation by 
Fetuin-B 
COCs of wildtype females were isolated and treated with hyaluronidase as described in 
chapter 2.1.4 in HTF medium without fetuin-B or HTF medium containing 1.0 mg/ml, 0.5 
mg/ml, 0.25 mg/ml, 0.125 mg/ml 0.063 mg/ml, 0.031 mg/ml or 0.015 mg/ml rmFetuB. All 
incubations were done at 37 °C in gassed (5% CO2, 5% O2, 90% N2) medium covered with 
mineral oil, pre-incubated over night. A minimum of 30 oocytes recovered from two to three 
cumulus-oocyte complexes from different females was used per condition. After one hour of 
in vitro cultivation the oocytes were fertilized as described at paragraph 2.1.5. Following four 
hours of incubation the zygotes were washed four times in 100 µl HTF medium without 
fetuin-B (because is was already known, that fetuin-B does no promote post-fertilization 
development and to diminish consumption of rmFetuB) to remove excess sperm and any 
residual debris. 24 hours later the embryos were evaluated and counted. To evaluate post-
fertilization ZP hardening sperm binding was quantified using a microscope as described in 
paragraph 2.2.3 (fixation was not necessary, because sperm already stopped moving). 
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Afterwards ZP of the two-cell embryos was digested with alpha-chymotrypsin as described at 
paragraph 2.2.2. 
 
2.4.5 Effects of Fetuin-B and Cumulus Cells on Zona Pellucida Hardening During In 
Vitro Cultivation 
Ten wildtype females with were used to isolate COCs as described at paragraph 2.1.4. One 
COC of each mouse was isolated in HTF medium without fetuin-B while the other COC was 
isolated in HTF medium containing 0.05 mg/ml rmFetuB. One half of the COCs that were 
isolated in fetuin-B free HTF medium were kept untreated, remaining the cumulus cells. For 
the other half as well as the COCs that were isolated in rmFetuB containing HTF medium 
cumulus cells were recovered by hyaluronidase treatment as described in chapter 2.1.4. 
After washing the oocytes of each condition were pooled in 400 µl medium. All incubations 
were done at 37 °C in gassed (5% CO2, 5% O2, 90% N2) medium covered with mineral oil, 
pre-incubated over night. A minimum of 30 oocytes per condition was either fertilized directly 
or after 1, 3, 5, 7, 9, 13, 17 or 25 hours of in vitro cultivation as described at paragraph 2.1.5. 
For each time point sperm were freshly isolated. Following four hours of incubation the 
zygotes were washed four times in 100 µl HTF medium without fetuin-B to remove excess 
sperm and any residual debris. 24 hours later the embryos were evaluated and counted. 
 
2.5 Statistics 
Data analysis was performed using GraphPad Prism software (Macintosh version 5.0c) and 
the statistical testing methods detailed in the figure legends. 
 
- Results - 
38 
3. Results 
3.1 Fetuin-B Deficient Female Mice are Infertile Due to an Early Block to 
Fertilization 
Laser-assisted in vitro fertilization (LA-IVF) and embryo transfer was performed in 
collaboration with Tanja Pfeffer and Professor René Tolba, RWTH Aachen.  
The female infertility of Fetub-/- female carrying the genetic C57BL/6 background, as well as 
the reduced fetuin-B serum concentration in Fetub+/- females were already known 18. First 
results indicated that the decreased fetuin-B serum concentration in Fetub+/- mice results in 
smaller litter sizes. Thus one aim of this thesis was to study the fertility of Fetub+/- females in 
a larger sample size of matings.  
To analyze fertility of Fetub+/- females, serum fetuin-B was measured using Western blotting 
as reported 18. Serum fetuin-B was measured in wildtypes as well as in fetuin-B 
heterozygous females (figure 9). Figure 9A shows a section of a representative Western Blot. 
Commercial recombinant murine fetuin-B (rmFetuB, Invigate) was used for calibration. The 
recombinant FetuB had a slightly higher molecular weight (approx. 65 kDa) than murine 
serum FetuB (60 kDa), likely due to an additional linker and His-Tag sequence added for 
purification of the recombinant FetuB. The size difference could be due to divergent post-
translational modification, like higher glycosylation or phosphorylation in the recombinant 
expression system. Furthermore it is conceivable that endogenous expressed fetuin-B is 
modified by endogenous factors resulting in a reduced molecular weight of serum fetuin-B. 
Serum of Fetub+/- females showed weaker signal intensity compared to Fetub+/+ female 
serum (figure 9A). Quantification of Fetub+/+ serum samples in figure 9B shows about 161.4  
± 10.5 µg/ml fetuin-B (mean ± SD, n=16). As expected, about half the normal amount of 
fetuin-B was present in Fetub+/- mice (89.8 ± 2.8 µg/ml, n=29), and Fetub-/- mice had no 
detectable fetuin-B.  
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A                B 
  
Figure 9. Heterozygous (+/-) females show half the fetuin-B serum concentration of wildtype (+/+). (A) 
Representative section of a murine Western blot. Molecular weight marker in kDa is indicated at the left. 
Commercial rmFetuB from 8.8 to 35.0 ng per lane and 0.2 µl of Fetub+/- or Fetub+/+ serum samples were loaded 
each. (B) Serum fetuin-B level was significant reduced in Fetub+/- females (89.8 ± 2.8 µg/ml, n=29) compared to 
wildtypes (161.4 ± 10.5 µg/ml, n=16). Boxes represents the first to the third quartile, band inside shows the 
median. Whiskers indicate 5-95 percentile. Pairwise two-sided t test ***p < 0.001  
 
To explore whether the Fetub+/- females are subfertile, all possible genotypes of females 
were mated with all possible genotypes of males. The results of these matings of mice 
carrying C57BL/6 genetic background are shown in table 7. The mean litter sizes of Fetub-/- 
and Fetub+/- females were compared with the litter size of Fetub+/+ females and the 
respective males. The infertility was observed exclusively in Fetub-/- female mice (table 7). 
Heterozygous females remained fertile and had mean litter sizes (all three mating groups of 
table 7 taken together: 6.8 ± 3.4, n = 59 gestations) comparable to wildtype females (6.0 ± 
1.9, n = 47 gestations) and also comparable to background specific published data (5.9 – 
7.7, see table 2). Thus first results showing smaller litter sizes of Fetub+/- females were not 
confirmed. Males of either genotype were fertile, too. This shows that even half the serum 
concentration of fetuin-B, like it was detected in Fetub+/- females, is sufficient to maintain 
fertility. 
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Table 7. Breeding performance of C57BL/6 mice. The mean litter sizes of Fetub-/- and Fetub+/- females were 
compared with the litter size of Fetub+/+ females and the respective males by pairwise two-sided t test, ***p < 
0.001, ns = not significant (modified from 17).  
C57BL/6  
female (n) x male (n) 
matings gestations pups mean ± SD 
litter size 
significance 
compared to +/+ 
-/- (18) -/- (15) 26 0 0 0.0 *** 
-/- (8) +/- (7) 8 0 0 0.0 *** 
-/- (12) +/+ (7) 12 0 0 0.0 *** 
+/- (19) -/- (11) 24 22 137 6.2 ± 3.4 ns 
+/- (19) +/- (13) 25 22 159 7.2 ± 3.9 ns 
+/- (13) +/+ (6) 16 15 103 6.9 ± 2.7 ns 
+/+ (15) -/- (8) 18 15 94 6.3 ± 1.6 - 
+/+ (9) +/- (6) 15 15 95 6.3 ± 2.0 - 
+/+ (17) +/+ (10) 24 17 91 5.4 ± 2.1 - 
 
Because the genetic background greatly affected the calcification phenotype of fetuin-A 
deficient mice, we also determined the infertility phenotype of fetuin-B deficient mice against 
two defined genetic backgrounds 8. Like in C57BL/6 mice, DBA/2 heterozygous females 
remained fertile and had mean litter sizes (all three mating groups of table 8 taken together: 
4.9 ± 2.5, n = 52 gestations) comparable to wildtype females (4.3 ± 1.9, n = 23 gestations, 
table 8). Mating of Fetub-/- males with Fetub+/- females even showed a statistically significant 
increased mean litter size compared to Fetub+/+ females that were mated with the identical 
Fetub-/- males (5.4 ± 3.4 vs. 4.3 ± 1.8). Compared to published data on background-specific 
litter sizes (4.9 – 5.7, see table 2) the general mean litter size was reduced, especially when 
using Fetub+/+ females. This could be due to the relatively low sample number of matings. 
For further evaluation the number should be increased. Males of either genotype were fertile, 
too. In conclusion, infertility of Fetub-/- female mice was independent of their genetic 
background and occurred in both C57BL/6 and DBA/2 inbred mouse strains.  
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Table 8. Breeding performance of DBA/2 mice. The mean litter sizes of Fetub-/- and Fetub+/- females were 
compared with the litter size of Fetub+/+ females and the respective males by pairwise two-sided t test, *p <0.05, 
***p < 0.001, ns = not significant (modified from 17).  
DBA/2 
female (n) x male (n) 
matings gestations pups mean ± SD 
litter size 
significance 
compared to +/+ 
-/- (8) -/- (5) 8 0 0 0.0 *** 
-/- (8) +/- (4) 10 0 0 0.0 *** 
-/- (11) +/+ (9) 16 0 0 0.0 * 
+/- (10) -/- (5) 18 18 97 5.4 ± 3.4 * 
+/- (20) +/- (8) 23 20 85 4.3 ± 1.8 ns 
+/- (15) +/+ (6) 16 14 71 5.1 ± 2.3 ns 
+/+ (5) -/- (4) 7 7 30 4.3 ± 1.8 - 
+/+ (7) +/- (6) 14 12 50 4.2 ± 2.0 - 
+/+ (6) +/+ (5) 6 4 18 4.5 ±1.7 - 
 
Earlier studies had indicated that a block of fertilization most likely caused the infertility in 
female Fetub-/- mice 17–19. This could be confirmed for both C57BL/6 and DBA/2 mice (figure 
10). About eight hours after mating, oocytes of fetuin-B deficient females were ovulated in 
well-organized cumulus-oocyte complexes (figure 10 A-D). After removal of the cumulus cells 
the oocytes of Fetub-/- mice lacked typical signs for fertilization, like an enlarged perivitelline 
space (figure 10 E-H).  
The total number of ovulated oocytes was comparable in Fetub-/- and wildtype (supplemental 
figure 1). After mating C57BL/6 wildtypes showed about 9.0 ± 1.7 ovulated oocytes per 
female (n=5), while Fetub-/- ovulated 10.2 ± 1.7 oocytes per female (n=6) and at DBA/2 
background 5.5 ± 1.5 (n=2) versus 8.8 ± 0.8 (n=10) ovulated oocytes per female, 
respectively. The tendency of DBA/2 mice to ovulate less oocytes than C57BL/6 is also 
reflected in the overall smaller litter sizes shown in table 7 and 8. No data were retrievable 
from published literature for spontaneous ovulation, because fertility studies generally use 
hormonal stimulation to increase number of ovulated oocytes per donor to minimize animal 
number. As expected, hormonal stimulation with PMSG followed by induction of ovulation by 
hCG, resulted in an increase of ovulated oocytes. Wildtypes showed about 14.9 ± 1.8 
ovulated oocytes per female (n=13), while Fetub-/- mice ovulated 22.2 ± 1.9 oocytes per 
female (n=20) in C57BL/6 background and 33.0 ± 6.3 (n=7) versus 27.8 ± 3.3 (n=10) at 
DBA/2 background, respectively. Published data state that C57BL/6 mice ovulate on average 
25.2 oocytes per donor after hormonal stimulation (superovulation), and DBA/2 34.2 oocytes 
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per female 173. Although the number of ovulated oocytes per donor was slightly reduced for 
both strains in the present work, the tendency of C57BL/6 mice to ovulate less oocytes than 
DBA/2 mice was confirmed. The fact that DBA/2 mice perform better under hormonal 
stimulation is surprising, because they ovulate less oocytes spontaneously after mating and 
also show smaller liter sizes. 
Earlier studies performed IVF with and without laser perforation of the ZP to test, if a defect 
in the ZP blocks fertilization 17,19. Conventional IVF of 162 C57BL/6 derived fetuin-B deficient 
oocytes remained unsuccessful, whereas 51% of wildtype oocytes became fertilized (n=345; 
figure 10 I, L). In contrast, laser assisted perforation of the ZP followed by IVF (LA-IVF) was 
met with success (figure 10 M, N). Of 172 wildtype oocytes, 50% became fertilized and 35% 
of 261 fetuin-B deficient oocytes, respectively. Experiments done with DBA/2 oocytes 
showed comparable results. None of the 55 fetuin-B deficient oocytes were fertilized after 
conventional IVF (figure 10 L), while 87% of the 88 wildtype oocytes developed to two-cell 
embryos (figure 10 K). LA-IVF led to a decreased fertilization success of 47% in wildtype 
oocytes (figure 10 O, n=30), which could be due to laser-induced oocyte damages as well as 
fetuin-B deficient oocytes (figure 10 P, n=45). After ZP laser perforation, fetuin-B deficient 
DBA/2 oocytes were fertilized as well, showing 47% of two-cell embryos. Thus both fetuin-B 
deficient oocytes carrying the C57BL/6 and the DBA/2 genetic background can be fertilized 
after overcoming the ZP by laser perforation.  
Because both mouse background strains, C57BL/6 and DBA/2, showed the same phenotype 
of fetuin-B deficiency, we concluded that infertility of Fetub-/- mice is genetic background-
independent. Therefore, all data that obtained with DBA/2 background mice thereafter are 
presented as supplemental material, while all results presented in the main text were 
obtained with C57BL/6 background mice. 
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Figure 10. Fetuin-B deficient oocytes can be fertilized in vitro after overcoming the ZP by laser 
perforation. (A) Wildtype (+/+) cumulus-oocyte complex (COC) and (B) COC isolated eight hours after mating 
from a C57BL/6 fetuin-B deficient (-/-) mouse or (C, D) from DBA/2 mice, respectively. (E) Oocyte isolated from a 
C57BL/6 wildtype female showed an enlarged perivitelline space compared to (F) an oocyte isolated from Fetub-/- 
female at day 0.5 after mating. (G, H) DBA/2 oocytes show the same results. Images of oocytes and two-cell 
embryos 1.5 days post-fertilization of (I, K) wildtype and (J, L) fetuin-B deficient oocytes recovered from C57BL/6 
or DBA/2 mice following conventional IVF, or (M-P) laser-assisted IVF (LA-IVF). Arrows point to the laser lesions. 
Bars in A-D indicate 200 µm, bars in E-P indicate 25 µm (modified from 17). 
 
Since fetuin-B deficient oocytes could be fertilized by LA-IVF we were interested to learn if 
these embryos would develop into healthy fetuses. Two-cell embryos, either derived from 
Fetub+/+ or Fetub-/- oocytes, developed into fetuses when transferred to wildtype foster 
mothers as shown in figure 11. For the wildtype control one of two foster mothers produced a 
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total of three offspring. Identical one of two foster mothers that got the Fetub-/- derived 
embryos produced a total of three offspring. Thus the fetal development of Fetub-/- derived 
embryos was unaffected.  
 
 
Figure 11. Fetuin-B deficient zygotes develop normal. (A - F) Photographs of fetuses dissected from wildtype 
foster mothers at day 16 following embryo transfer of LA-IVF fertilized oocytes. (G, H) Histological sections of 
fetuses after H&E staining showed all essential organs and no abnormalities. ag = adrenal gland, bb = backbone, 
bl = bladder, br = brain, gu = gut, he = heart, ki = kidney, li = liver, lu = lung, sg = salivary gland, sp = spleen,  th = 
thymus, to = tongue (modified from 17).  
 
To study the rearing potential of fetuin-B deficient females, two-cell embryos delivered by 
laser-assisted IVF using either fetuin-B deficient or wildtype oocytes were transferred into 
fetuin-B deficient females. All of three Fetub-/- foster mothers that received Fetub-/- embryos 
became pregnant and produced a total of seven offspring (2.3 pubs per litter). From four 
Fetub-/- foster mothers that received Fetub+/- embryos three became pregnant and produced 
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a total of 14 offspring, while one mother had eaten her pups, so that the size of this litter 
could not be observed (7.0 pups per litter). These results show, that fetuin-B deficient 
embryos are able to develop into healthy young in a complete fetuin-B free environment.  
To sum up we showed that half the fetuin-B serum concentration in Fetub+/- mice is sufficient 
to maintain fertility. Female infertility of Fetub-/- mice is caused by blocked fertilization. After 
overcoming the ZP barrier, fetuin-B deficient oocytes could be fertilized and developed into 
healthy offspring after transfer into Fetub-/- foster mothers. Thus maternal fetuin-B is not 
essential for later stages of pregnancy, such as implantation and the maintenance of 
pregnancy. The infertility of fetuin-B deficient females is exclusively mediated by blocked 
fertilization. 
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3.2 Fetuin-B Deficient Oocytes Undergo Premature Zona Pellucida Hardening 
Earlier work had demonstrated that commercial fetuin preparations can prevent ZP 
hardening 148,152,154,155. The authors could not discriminate between fetuin-A and fetuin-B at 
the time, because the existence of two distinct fetuin proteins was unknown until the year 
2000. Considering that fetuin-A deficient mice have a severe phenotype of soft tissue 
calcification, yet are fully fertile 7,8 we reasoned that the infertility of the Fetub-/- mice was due 
to defective ZP maturation in the absence of fetuin-B. Indeed bovine fetuin preparations that 
had prevented ZP hardening in vitro, contained fetuin-B (figure 12). Human follicular fluid 
was also already shown to inhibit premature ZP hardening, and likewise scored positive for 
fetuin-B as well. Thus the demonstrated ZP hardening inhibition effected of bovine fetuin 
preparations was likely due to their fetuin-B content. Human fetuin-A, BSA and HSA showed 
no fetuin-B signal, consistent with the fact that these proteins are incapable of inhibiting ZP 
hardening 155. Therefore, we reasoned that the defective ZP observed in fetuin-B deficient 
oocytes was due to premature ZP hardening.  
Furthermore, we asked how fetuin-B reached the oocytes despite the virtual absence of 
ovarian expression compared to liver expression 2. Western blotting detected fetuin-B in 
human follicular fluid in amounts similar to human serum suggesting transfer of fetuin-B from 
blood into follicular fluid (figure 12). Thus fetuin-B surrounds the oocyte during the 
development. 
 
Figure 12. Commercial fetuin preparations with zona pellucida hardening inhibition activity contain fetuin-
B. Human fetuin-B antibody, which shows cross-reactivity with murine and bovine fetuin-B, was used to probe for 
fetuin-B in sera of wildtype, Fetub-/- and Fetua-/- mice, as well as various commercial bovine fetuin preparations, 
Dade-Behring human plasma fetuin-A/Ahsg (hu fetuin-A), bovine serum albumin (BSA), human serum albumin 
(HSA), human serum and human follicular fluid. Molecular weight is indicated at the right (modified from 17). 
 
To study oocyte defects, we first analyzed general oocyte morphology. The diameter of 
fetuin-B deficient oocytes (69.0 ± 4.2 µm, figure 13 left) was comparable to wildtype oocytes 
(69.3 ± 4.2 µm) and also in line with published data 174. Descriptive data about the ZP 
thickness of individual unfertilized oocytes range from 4.3 – 8.1 µm 175. Diameters of ZP had 
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large variation depending on the mouse background strain 176–179. According to the literature 
C57BL/6 oocytes have a ZP thickness of 7.59 ± 0.07 µm, very close to what was measured 
here (7.58 ± 0.96 µm, figure 13 right) 178. In comparison DBA/2 are meant to have a thinner 
ZP, which could however, not be confirmed (7.70 ± 0.70 µm, supplemental figure S7) 179.  
 
Figure 13. Zona pellucida of fetuin-B deficient oocytes is thinner. (left) Diameter of wildtype oocytes (+/+, 
69.25 ± 4.19 µm, n = 137) and Fetub-/- derived oocytes (-/-, 68.96 ± 4.16 µm, n = 196). (right) ZP thickness of 
wildtype oocytes (7.58 ± 0.96 µm, n = 137), Fetub-/- derived oocytes (6.54 ± 0.95 µm, n = 196) and wildtype 2-cell 
stage embryos (6.95 ± 0.70 µm, n = 108). Boxes represents the first to the third quartile, band inside shows the 
median. Every dot represents one oocyte as outliers. Whiskers indicate 5-95 percentile. Pairwise two-sided t test 
ns = not significant, ***p<0.001 (modified from 17). Background strain was C57BL/6, data for DBA/2 mice are 
shown in supplemental figure S7. 
 
After fertilization, ZP2 is cleaved resulting in structural ZP modifications. As a consequence 
ZP thickness decreases, which is readily visible in the present data (figure 13 right). ZP 
thickness of two-cell embryos (6.95 µm), which have a physiologically hardened ZP, was 
significantly reduced compared to unfertilized wildtype oocytes (7.58 µm), but was 
indistinguishable from fetuin-B deficient oocytes (6.54 µm). This indicated that fetuin-B 
deficient oocytes indeed show structural variations in their ZP and that this could be the 
reason for the observed fertilization block. In general ZP thickness correlates with fertilization 
success but not with ZP hardening by force 177,180,181. Thus we checked Fetub-/- oocytes 
specific for ZP hardening. 
ZP hardening is associated with increased resistance to proteolytic degradation 112. Thus we 
analyzed chymotrypsin-mediated ZP digestion in unfertilized fetuin-B deficient and wildtype 
oocytes, as well as two-cell embryos, which represent the physiologically hardened ZP 
phenotype. Figure 14 shows photographs of representative oocytes and two-cell embryos 
during proteolytic degradation of the ZP. Unfertilized wildtype oocytes showed clear signs of 
ZP degradation after less than one minute of chymotrypsin digestion (figure 14, upper row). 
The oocyte was free of visible ZP after a further five minutes. In Fetub-/- derived oocytes 
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(figure 14, middle row) the ZP degradation started after about 16 minutes and was completed 
after ten additional minutes. The two-cell embryo (figure 14, bottom row), which represents 
the physiologically hardened ZP phenotype, showed first signs of ZP degradation after about 
32 minutes and took about ten more minutes, comparable to the Fetub-/-. 
 
 
Figure 14. Zona pellucida of fetuin-B deficient oocytes is more resistant against enzymatic digestion. 
Microscopic pictures of a wildtype (+/+) and a fetuin-B deficient (-/-) oocyte as well as a two-cell embryo during 
proteolytic ZP degradation with chymotrypsin. Numbers in the left corners represent the time of chymotrypsin 
treatment in minutes. 
 
We measured chymotrypsin-mediated ZP digestion time in unfertilized fetuin-B deficient and 
wildtype oocytes, as well as two-cell embryos (for each condition n ≥ 20; 4 independent 
experiments). Figure 15 shows that t50, the time required to digest the ZP in half of the 
oocytes in each matching series, was 5 times longer in fetuin-B deficient oocytes (31.5 min 
± 4.7 min) than in unfertilized wildtype oocytes (6.4 min ± 0.9 min). Furthermore, the ZP 
digestion time of fetuin-B deficient oocytes was comparable to that of wildtype two-cell 
embryos (38.5 min ± 6.0 min), indicating that the ZP structure of fetuin-B deficient oocytes 
resembled a hardened phenotype.  
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Figure 15. Zona pellucida digestion time is increase in fetuin-B deficient oocytes. ZP digestion times of 
wildtype oocytes (+/+), fetuin-B deficient oocytes (-/-) and wildtype 2-cell stage embryos. The ZP digestion time 
t50 equals the time required for 50% of the oocytes to become zona-free following α-chymotrypsin treatment. 
Every dot represents one assay performed with at least 20 oocytes harvested from one mouse. Pairwise two-
sided t test **p<0.01, ns = not significant (modified from 17). Background strain was C57BL/6, data for DBA/2 mice 
are shown in supplemental figure S7. 
 
Post-fertilization oocyte ZP hardening results in a block to further sperm binding. Figure 16 
shows that oocytes obtained from superovulated Fetub-/- mice (figure 16 B) indeed had 
strongly reduced sperm binding compared to wildtype oocytes (figure 16 A), even less than 
two-cell embryos (figure 16 C). Numbers of bound sperm are shown in the graph in figure 16 
D. Unfertilized Fetub+/+ oocytes showed 52.9 ± 3.0 bounded sperm per oocyte (mean ± SD; 
n=103), compared to 3.6 ± 0.6 bounded sperm at Fetub-/- oocytes (n=121) and 10.3 ± 2.2 at 
two-cell embryos (n=37), respectively. Thus fetuin-B deficient oocytes showed a statistical 
significant reduction in sperm binding compared to wildtypes. This supports the view that 
oocytes from Fetub-/- had undergone ZP hardening even without fertilization. Compared to 
two-cell embryos, which represent the physiological hardened phenotype, sperm binding to 
Fetub-/- oocytes was also statistical significant decreased. Oocytes were isolated about 16 
hours post-ovulation induction via hCG injection. With the assumption that spontaneous 
cortical granula release mainly occurs around ovulation, this would mean that ZP hardening 
in Fetub-/- oocytes started 16 hours before sperm binding was tested. Two-cell embryos were 
obtained by IVF and used for sperm binding about 24 hours after fertilization. Thus two-cell 
embryos had more time to undergo ZP-hardening and one would expect that sperm binding 
should be lower compared to Fetub-/- oocytes. Furthermore Burkart et al. showed that 
recombinant ovastacin takes in vitro about eight hours to completely cleave ZP2 of isolated 
ZPs 122. Thus after 16 hours for the Fetub-/- oocytes and 24 hours for the two-cell embryos 
ZP2 should be completely cleaved. As a consequence time should not be the factor leading 
to different degrees of ZP hardening in two-cell stages and Fetub-/- oocytes. As already 
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mentioned two-cell embryos were observed by IVF. Therefor COCs of wildtype females were 
isolated and sperm was directly added without previous removal of the cumulus cells. Thus 
we hypothesize that some fetuin-B was left in the environment during IVF, leading to a 
particular inhibition of ZP2 cleavage in the two-cell embryos and thus to a more drastic ZP 
hardening in Fetub-/- oocytes. 
 
  
Figure 16. In vitro sperm binding is decreased at fetuin-B deficient oocytes compared to wildtype 
oocytes. (A) Microscopic picture of a representative wildtype oocyte with a high amount of attached sperm. (B) At 
the fetuin-B deficient oocyte the sperm binding was reduced and the amount of attached sperm was even less 
compared to (C) the two-cell embryo. (D) Box plot representing sperm binding quantification. Sperm binding was 
significant decreased in fetuin-B deficient oocytes (-/-) compared to wildtype oocytes (+/+) and even less 
compared to two-cell embryos. Boxes represents the first to the third quartile, band inside shows the median. 
Every dot represents one oocyte as outliers. Whiskers indicate 5-95 percentile. Pairwise two-sided t test ns = not 
significant, ***p<0.001 (modified from 17). Background strain was C57BL/6, data for DBA/2 mice are shown in 
supplemental figure S7. 
 
Proteolytic cleavage of ZP2, a hallmark of ZP hardening, was analyzed using monoclonal 
antibody directed against ZP2 111,182. Western blots of extracts prepared from unfertilized 
wildtype oocytes showed a signal at 120 kDa that corresponds to uncleaved ZP2 protein 
(figure 17). Two-cell embryos showed an additional signal at 90 kDa that corresponds to the 
cleaved ZP2f protein as expected. It is known that partial ZP2 cleavage is sufficient to block 
sperm binding and fertilization, thus the incomplete ZP2 cleavage after fertilization was 
expected 146. The incomplete ZP2 cleavage further confirmed results that were seen in sperm 
binding experiments and corroborates the hypothesis that the IVF received two-cell embryos 
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only showed partial ZP-hardening, eventually due to residual fetuin-B after COC isolation. As 
expected fetuin-B deficient oocytes showed a stronger signal at the molecular weight of ZP2f 
compared to two-cell embryos, as they also showed less sperm binding  (figure 17).  In 
Fetub-/- oocytes derived from DBA/2 mice ZP2 in fact was completely cleaved, eventually 
indicating some strain specific differences in sensibility to premature ZP hardening 
(supplemental figure S7).   
Spontaneous degranulation mainly occurs around ovulation. About one quarter of the cortical 
granules is released around this time period 49. Thus one would expect that premature ZP 
hardening in Fetub-/- mice becomes manifest at ovulation. For examination we either 
stimulated Fetub-/- females with PMSG only, and isolated oocytes directly from the ovary 
(pre-ovulatory), or we further induced ovulations by hCG injection and isolated COCs from 
the oviduct (post-ovulatory). Indeed pre-ovulatory fetuin-B deficient oocytes only showed the 
uncleaved ZP2 protein, while in fetuin-B deficient oocytes the cleaved ZP2f protein band 
could be detected post-ovulatory (figure 17). This lead to the conclusion that premature ZP 
hardening in Fetub-/- mice started at ovulation and was probably already progressed too far 
for successful fertilization before the sperm reach the oocyte.  
 
 
Figure 17. Fetuin-B deficient oocytes show premature ZP2 cleavage that persists after ovulation. Immune 
detection of ZP2 protein of wildtype (+/+) oocytes, fetuin-B deficient (-/-) oocytes and wildtype 2-cell embryos. 
Fetuin-B deficient oocytes were further isolated pre- and post-ovulatory (modified from 17). Background strain was 
C57BL/6, data for DBA/2 mice are shown in supplemental figure S7. 
 
In summary, it can be stated that the ZP of fetuin-B deficient oocytes had hardened 
prematurely during ovulation and, accordingly, that infertility in Fetub-/- females was due to 
premature ZP hardening, evaluated by measurements of ZP thickness, chymotrypsin 
digestion, sperm binding and ZP2 Western blot. In Fetub-/- mice ZP hardening occurred at 
ovulation. Compared to two-cell wildtype embryos, Fetub-/- oocytes even showed a higher 
degree of ZP hardening, indicating that ZP hardening in two-cell embryos might still be 
partially inhibited by COC-stored endogenous fetuin-B. 
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3.3 Fetuin-B Inhibits Ovastacin and Thus Zona Pellucida Hardening 
This part of the thesis work was performed in collaboration with Ralf Weiskirchen and Julia 
Floehr, RWTH Aachen and Walter Stöcker, Johannes-Gutenberg-University Mainz and their 
co-workers who prepared recombinant fetuins and studied ovastacin inhibition, respectively.  
We already showed that oocytes of Fetub-/- undergo premature ZP hardening. Several 
factors are discussed to be involved in fertilization-triggered ZP hardening, while only the 
cortical granula protease ovastacin was shown to be critically involved in definitive ZP 
hardening by cleaving ZP2 122. To draw a conclusion on the mechanism between fetuin-B 
and ZP hardening it was of great interest if recombinant mouse fetuin-B inhibits mouse 
ovastacin activity. To this end, we cloned mouse fetuin-A and fetuin-B into adenoviral 
expression vectors and purified His-tagged fusion proteins from virus infected cell 
supernatants. In addition, we expressed recombinant ovastacin in insect cells. Figure 18 
shows that activated ovastacin was inhibited to background activity by recombinant fetuin-B 
(IC50 76.4 nM ± 3.35 nM), but not by recombinant fetuin-A. In the assay 990 nM pro-
ovastacin was used, containing about 10% of activated ovastacin. Thus 76.4 nM 
recombinant fetuin-B were sufficient to decrease the activity of 99.0 nM activated ovastacin 
to the half, reflecting a molecular fetuin-B : ovastacin ratio of about 1:1.3. The concentrations 
of fetuin-B and ovastacin at the ZP are not known and can only be roughly estimated. It is 
known that about 100 pg protein are released into the perivitelline space after fertilization 
69,110. Having regard to the data that one quarter of the cortical granula is already released at 
ovulation this would mean that about 33.3 pg of cortical granula protein is exocytosed 
spontaneously (100 pg / ¾ * ¼ = 33.3 pg). Unfortunately the amount of released ovastacin is 
not known. With the assumption that 33.3 pg ovastacin (50 kDa) is released into the 
perivitelline space with a volume of 82 pl (calculated from measurements of perivitelline 
space diameter of 137 mature wildtype oocytes with 9.3 ± 0.40 µm, for detailed calculation 
see supplemental figure S8), this would lead to a ovastacin concentration of 0.4 g/l ovastacin 
in the perivitelline space. Considering the molecular weight of ovastacin this would result in a 
concentration of 8.1 µM ovastacin in the perivitelline space. Fetuin-B has a molecular weight 
of 60 kDa and is thought to diffuse unhindered through the cumulus cell matrix as well as the 
ZP. With the knowledge that fetuin-B serum concentration in wildtype mice is about 0.275 g/l 
and with the assumption that it is the same in the perivitelline space this would lead to a 
concentration of 4.6 µM fetuin-B. Thus the molecular fetuin-B : ovastacin ratio at 
spontaneous cortical granula release would be about 1:1.8, similar as shown in the in vitro 
ovastacin inhibition assay. Thus we suggest that premature ZP hardening triggered by 
spontaneous cortical granula release of ovastacin should be entirely prevented by the 
micromolar concentrations of fetuin-B present in plasma and follicular fluid. 
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Figure 18. Recombinant ovastacin is inhibited by recombinant mouse fetuin-B (circles; concentration range: 
0.6 nM - 4.5 µM) with an IC50 of 76.4 nM ± 3.4 nM. In contrast, recombinant murine fetuin-A did not inhibit 
ovastacin (squares; concentration range: 0.6 nM – 11.0 µM) (modified from 17). 
 
In conclusion, fetuin-B but not fetuin-A inhibited the ZP2 protease ovastacin. Taken together 
with the fact that bovine fetuin comprises fetuin-A and fetuin-B (paragraph 3.2, figure 12) we 
hypothesizes that earlier shown inhibition of ZP hardening by bovine fetuin was mediated by 
fetuin-B and not by fetuin-A as predicted at that time.  
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3.4 Fetuin-B Increases Fertilization Success in Vitro 
Commercial bovine fetuin preparations contain both fetuin-A and -B, and therefore can inhibit 
premature ZP hardening in vitro leading to a increased fertilization success 148,154,155. We 
showed that recombinant murine fetuin-B, but not recombinant murine fetuin-A inhibits the 
ZP2 protease ovastacin. Thus I asked if recombinant murine fetuin-B could inhibit premature 
ZP hardening during IVF treatment and thus increase fertilization success like it was shown 
earlier for mixed bovine fetuin preparations. 
Fetuin-B was cloned into adenoviral expression vectors by Eddy van de Leur and Ralf 
Weiskirchen, RWTH Aachen. His-tagged fusion protein was purified from virus infected COS 
cell supernatants by Julia Floehr, RWTH Aachen. Recombinant murine fetuin-B (rmFetuB) 
was stored in PBS at concentrations of about 3.0 mg/ml. Schröder et al. showed best 
fertilization success with the use of 1.0 mg/ml bovine fetuin at IVF 155. Due to the lack of 
knowledge about the ratio of fetuin-A and fetuin-B in the bovine fetuin we decided to start 
with a concentration of 1.0 mg/ml rmFetuB in the IVF experiments. This would have lead to a 
dilution of about 1:3 of the purified rmFetuB and thus to a high concentration of PBS in the 
IVF experiments. PBS is suspected to induce cortical granula release and thus spontaneous 
ZP hardening. To avoid PBS-induced ZP damages, we exchanged the buffer using 
centrifugal desalting devices. First results showed that the direct transfer from PBS to human 
tubal fluid (HTF) medium using the desalting devices caused precipitation of unidentified 
components. One likely explanation for precipitation was the formation of insoluble 
phosphate salts from PBS and HTF. Thus I performed a two-step buffer change, first 
exchanging the recombinant fetuin-B from PBS to ultrapure water and then to HTF medium. 
Each intermediary preparation was assayed for protein loss. A typical fetuin-B Western blot 
is shown in figure 19. Sequential dilutions of commercial rmFetuB were used for quantitation 
as before (figure 9, measurement of fetuin-B serum concentration). Both recombinant murine 
fetuin-B preparations (commercial and in-house expression) showed the same molecular 
weight of approximate 65 kDa. In house-produced rmFetuB had fragments at about 41 kDa, 
43 kDa, 49 kDa and 50 kDa. 
To transfer rmFetuB to HTF medium the column was first equilibrated four times with 
ultrapure water. After loading the purified protein (load) to the column and centrifugation the 
fetuin-B was transferred into ultrapure water (eluate 1). Afterwards the column was washed 
four times and thus equilibrated with HTF medium without BSA. RmFetuB in water (eluate 1) 
was loaded onto the same column and centrifuged to recover rmFetuB in HTF medium 
(eluate 2). As expected, the load as well as the eluates scored positive for fetuin-B (figure 
19). Although the wash fractions (W1, W2) showed no fetuin-B signal, the signal in the 
eluates decreased in subsequent fractions, most likely due to dilution. Quantitation using 
ImageJ software showed a concentration reduction from 3.27 mg/ml (load) to 2.60 mg/ml 
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(eluate 1, E1) and further to 2.08 mg/ml (eluate 2, E2), which means that over all about 36 % 
of the protein was lost due during buffer exchange. Pipetting a small bulb at the column after 
sample loading might have increased recovery, but we decided against this procedure to 
avoid contamination of the IVF medium by overloading the column.  
 
 
Figure 19. Evaluation of recombinant murine fetuin-B buffer transfer from PBS to HTF medium. Murine 
fetuin-B Western blot of rmFetuB buffer transfer procedure showed fetuin-B signal in load, first eluate (E1) and 
second eluate (E2), but not in the wash fractions (W1, W2). 
 
Finally the eluate contained 2.08 mg/ml rmFetuB in HTF medium without BSA or antibiotics. 
To add BSA, rmFetuB in HTF medium without BSA and antibiotics was mixed with the same 
volume of HTF medium containing 2 X BSA and antibiotics (8 mg/ml BSA, 150 µg/ml 
penicillin, 100 µg/ml  streptomycin). HTF medium with 1.04 mg/ml rmFetuB was either used 
directly or diluted to obtain HTF medium containing 0.5 mg/ml, 0.25 mg/ml, 0.125 mg/ml, 
0.063 mg/ml, 0.031 mg/ml or 0.015 mg/ml fetuin-B. 
The rmFetuB fortified HTF medium was used to study the impact of fetuin-B on fertilization 
success during IVF. 
In the first experiment COCs of three wildtype females each were flushed directly into HTF 
medium without fetuin-B or into HTF medium supplemented with 1.0 mg/ml rmFetuB. 
Capacitated sperm was added immediately after COC isolation. The total procedure from 
sacrifice of the females to adding the sperm to COC took less than five minutes. The time 
line of a typical experiment is illustrated in figure 20. After four hours of fertilization the 
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oocytes were washed three times and placed into a fresh drop of either HTF medium without 
fetuin-B or HTF medium supplemented with 1.0 mg/ml rmFetuB. Another 20 hours later the 
number of two-cell embryos was counted to determine the fertilization success. Thereafter, 
half the embryos were transferred to M2 medium to support further development and the 
other half was analyzed for ZP hardening. 
 
 
Figure 20. Time line of testing the impact of fetuin-B on fertilization and embryo development. COCs were 
isolated and sperm were immediately added. After four hours potential zygotes were wash. After 24 hours 
number of two-cell embryos was quantified. One half of the cells was used for ZP digestion with chymotrypsin 
while the other half was transferred to M2 medium to analyze further development. After 48 and 120 hours the 
amount of four-cell embryos and blastocysts was quantified, respectively. Gray section determines the presence 
of rmFetuB during incubation. 
 
Independent of whether fetuin-B was contained in the medium or not, the embryos 
developed to the two-cell stage 24 hours post-fertilization (figure 21 A-D). Embryos that were 
fertilized in rmFetuB-containing HTF medium had larger numbers of sperm attached. This 
indicates that 1 mg/ml rmFetuB was sufficient to inhibit not only premature, but also 
fertilization-triggered ZP hardening. One would have expected that the inhibition of 
premature ZP hardening by fetuin-B should increase the proportion of two-cell embryos. 
Instead the fertilization success as well as the amount of fragmented, degraded embryos 
was comparable in both groups as shown in figure 21 E. With rmFetuB in the IVF medium, 
71.2% developed into two-cell embryos, which was slightly less than without the 
supplementation of rmFetuB (77.1%). Fertilization success was nevertheless higher than in 
our previous work (50% fertilization success, see paragraph 3.1, figure 10), and also higher 
than in published data (66.2% fertilization success, see paragraph 1.4, table 2). ZP 
hardening is thought to prevent polyspermy. Pictures of two-cell embryos fertilized in a fetuin-
B enriched environment indicated inhibition of ZP hardening. Thus one would have expected 
that the inhibition of fertilization-triggered ZP by fetuin-B should increase polyspermy and 
thus the percentage of degenerative embryos. Instead the amount of degenerative oocytes 
was comparable in both setups (figure 21 E). About 8.6% of oocytes degenerated in the 
absence of rmFetuB, and 5.1% degenerated with rmFetuB supplementation, respectively. To 
test two-cell embryos for ZP hardening the ZP was digested using chymotrypsin. Two-cell 
embryos that were fertilized in fetuin-B free medium showed a t50 of 32.1 min and were 
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comparable to earlier results (38.5 min for two-cell embryos and 31.5 min for Fetub-/- 
oocytes, see paragraph 3.2, figure 14), indicating fertilization-triggered ZP hardening. Two-
cell embryos that were fertilized in fetuin-B supplemented medium showed a t50 of 16.0 min, 
which was 2.5 times longer than t50 of unfertilized Fetub+/+ oocytes (6.4 min see paragraph 
3.2, figure 14), but only half as long as two-cell embryos that were fertilized in fetuin-B free 
HTF medium. Thus it appeared as if rmFetuB did not completely inhibit fertilization-triggered 
ZP hardening.  
Two-cell embryos, regardless of whether they were fertilized with or without fetuin-B, further 
developed into four-cell embryos 48 hours after fertilization (figure 21 F-I) , and further into 
blastocysts 120 hours after fertilization (figure 21 K, L). At the four-cell stage, both groups 
showed a decrease in percentage of healthy embryos compared to two-cell stages (figure 21 
E, J). With the use of rmFetuB in the IVF medium, 67.6% developed to four-cell embryos and 
without the supplementation of rmFetuB 75.6%, respectively. The numbers further dropped 
until the blastocyst stage and were nearly identical for both groups (figure 21 O, 52.9% with 
rmFetuB, 52.5% without rmFetuB). Blastocysts in both groups started to hatch or already 
finished hatching leaving the empty ZP (figure 21 M, N).  
Oocytes isolated from Fetub-/- females could not be fertilized in vitro with supplementation of 
rmFetuB, showing that premature ZP hardening is irreversible. 
The lack of a positive effect of fetuin-B on IVF fertilization success may be explained as 
follows. Firstly, the time between COC isolation and sperm adding was less than five minutes 
and thus likely to short to study ZP hardening. Second the extracellular matrix of the cumulus 
cells could store endogenous fetuin-B like already hypothesized in paragraph 3.2. To avoid 
confounding effects of endogenous fetuin-B during further experiments, I removed cumulus 
cells from oocytes by hyaluronidase digestion before using the oocytes for IVF assays. 
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Figure 21. Recombinant murine fetuin-B did not influence embryo development. COC were either isolated 
in HTF medium without (wo) rmFetuB or supplemented with 1.0 mg/ml rmFetuB. (A-E) 24, (F-J) 48 and (K-O) 120 
hours microscopic photos were taken and percentage of health embryos was quantified. Bar in picture N indicates 
50 µm, all microscopic photographs were taken using the same magnification. 
 
Next I analyzed the time point at which premature ZP hardening manifests during in vitro 
cultivation (IVC). Dodson et al. showed that ZP resistance to proteolytic digestion started to 
increased 40 hours after ovulation in vivo, while fertilization already decreases 15 minutes 
after IVC 146,147. Thus we studied ZP hardening for up to 36 hours of IVC. Time frame of the 
entire experiment is illustrated in figure 22. After isolation, COCs were digested with 
hyaluronidase and oocytes were washed three times in HTF medium, to get rid of the 
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cumulus cells and associated endogenous fetuin-B. Oocytes were pooled in one drop of HTF 
medium without any fetuin-B supplementation. At different time points a sample of 20-30 
oocytes was used for ZP digestion to analyze ZP hardening. 
 
 
Figure 22. Timing diagram of analyzing ZP hardening after cumulus cell removal and IVC. COCs were 
isolated and cumulus cells were removed. After 0, 1, 2, 4, 6, 8, 10, 12, 16, 20, 24, 28, 32 and 36 hours of IVC 
(indicated by arrows) ZP hardening was examined by ZP digestion of 20-30 oocytes by chymotrypsin. The entire 
experiment was done without the use of rmFetuB. 
 
Figure 23 shows that t50, the time required to digest the ZP in half of the oocytes in each 
matching series, increased from 8.3 min ± 0.9 min in oocytes that were immediately tested 
after isolation (0 hours of IVC) to 16.3 min ± 2.0 min after one hour of IVC and further to 19.8 
min ± 0.1 min after two hours of IVC. Fetuin-B deficient oocytes were used as control, and 
had a t50 of 30.5 min (± 1.4 min). Results were comparable with earlier experiments (figure 
15) with t50 of 31.5 min ± 4.7 min in fetuin-B deficient oocytes and 6.4 min ± 0.9 min in 
unfertilized wildtype oocytes, respectively. After two hours of IVC, the t50 remained constant, 
indicating that ZP hardening had completed. Hardened ZP of IVC oocytes nevertheless  
never reached the t50 values of fetuin-B deficient oocytes. This can be explained by the fact 
that the wildtype oocytes, used in this assay still were surrounded by endogenous fetuin-B at 
ovulation and until isolation. Thus a certain proportion of the released ovastacin likely was 
inhibited before isolation and cumulus cell removal, which is of cause not the case in fetuin-B 
deficient mice. Nevertheless I observed increased ZP resistance against enzymatic digestion 
within one hour of fetuin-B free IVC and thus decided to pre-incubate the oocytes in HTF 
medium for one hour before sperm addition for the further experiments to trigger partial ZP 
hardening. 
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Figure 23. ZP hardening occurred after one hour of in vitro cultivation (IVC). ZP digestion times of wildtype 
oocytes undergoing different durations of IVC and fetuin-B deficient oocytes (-/-). The ZP digestion time t50 
equals the time required for 50% of the oocytes to become zona-free following alpha-chymotrypsin treatment. 
Every column represents at least two assays performed with 20-30 oocytes each. Pairwise two-sided t test * 
p<0.05; ** p<0.01 
 
I demonstrated that the use of fetuin-B at oocyte isolation without cumulus cell removal and 
immediate fertilization inhibited premature ZP hardening, but did not increase fertilization 
success. Furthermore the inhibition of fertilization-triggered ZP hardening did not lead to 
polyspermy. I also showed that premature ZP hardening manifests within one hour after 
oocyte isolation and removal of the cumulus cells.  
Next, I analyzed if fetuin-B supplementation can inhibit premature ZP hardening during IVC. 
The time line of the entire experiment is illustrated in figure 24. After COC isolation and 
cumulus cell removal the oocytes were cultured in vitro for one hour to trigger partial ZP 
hardening in either HTF without rmFetuB or in HTF with rmFetuB. Four hours after the 
addition of sperm, zygotes were washed three times in HTF medium. To avoid the inhibition 
of fertilization-triggered ZP hardening, but also to minimize the amount of rmFetuB required, 
all oocytes were washed in HTF without rmFetuB. 24 hours after the addition of sperm the 
number of two-cell embryos was counted as well as the number of sperm bound per two-cell 
embryo. Post-fertilization ZP hardening was evaluated by ZP digestion of two cell embryos 
using chymotrypsin. 
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Figure 24. Timing diagram of testing the impact of fetuin-B after removal of the cumulus cells and one 
hour of IVC. COCs were isolated and cumulus cells were removed. After one hour of IVC sperm were added. 
After additional four hours potential zygotes were washed in fetuin-B free HTF medium. 24 hours post-fertilization 
the amount of two-cell embryos was quantified. To test ZP hardening bounded sperm per two-cell embryo were 
counted and ZP was digested by chymotrypsin. Gray section determines the presence of rmFetuB during 
incubation. 
 
In the previous experiment I used HTF medium with 1.0 mg/ml rmFetuB, and I inhibited 
premature ZP hardening, but also fertilization-triggered ZP hardening. Fetub+/+ female mice 
showed serum concentrations of 161.4  ± 10.5 µg/ml fetuin-B (see paragraph 3.1 and figure 
9). Half the serum fetuin-B level was sufficient to maintain fertility of Fetub+/- females in vivo. 
To test the inhibition potential of fetuin-B in vitro, I used rmFetuB concentrations ranging from 
0.015 mg/ml to 1 mg/ml. Oocytes were either isolated in fetuin-B free HTF medium or in HTF 
medium containing rmFetuB, and cumulus cells were removed. After one hour of IVC (to 
trigger premature ZP hardening) oocytes were fertilized by adding sperm into the medium. 24 
hours post-fertilization the number of two-cell embryos was counted. The number of sperm 
attached per two-cell embryo and proteolytic resistance of ZP was determined to analyze for 
the persistence of fertilization-triggered ZP hardening.  
The top panel of figure 25 shows the benefit of different concentrations of fetuin-B to IVF 
success. The middle and bottom panel of figure 25 illustrate fertilization-triggered ZP 
hardening mediated by attached sperm per two-cell embryo (middle), and t50 at ZP digestion 
(bottom). Light gray bars indicate mean serum fetuin-B level in Fetub+/- mice and dark gray 
bar indicate mean serum fetuin-B level in Fetub+/+ mice. Even the lowest concentration of 
0.015 mg/ml rmFetuB increased the amount of two-cell embryos. Oocytes that were isolated 
in fetuin-B free medium showed a fertilization success of 36.1%, while oocytes isolated in 
medium supplemented with 0.015 mg/ml to 0.1 mg/ml rmFetuB showed increased 
fertilization success of 61.4% and 74.5%. Thus without rmFetuB oocytes had probably 
undergone premature ZP hardening, while the use of fetuin-B during IVC and IVF inhibited 
premature ZP hardening and thus increased fertilization success. 
In fetuin-B free HTF medium two-cell embryos showed a relatively low number of attached 
sperm (56.3 ± 30.5 sperm per two cell embryo) and a relatively high resistance to ZP 
digestion (t50 of 19.6 ± 3.4 min), indicating fertilization-triggered ZP hardening. The use of 
0.015 mg/ml rmFetuB increased the number of attached sperm (121.3 ± 30.9 sperm per two-
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cell embryo) and slightly decreased the t50 of ZP digestion to 18.0 ± 3.4 min. 
Supplementation of HTF medium with 0.03 mg/ml rmFetuB further increased the number of 
attached sperm (145.0 ± 39.9 sperm per two-cell embryo) and further decreased the t50 of 
ZP digestion to 15.8± 2.9 min. Further increase of fetuin-B concentration showed results 
comparable to 0.03 mg/ml rmFetuB. Thus 0.015 mg/ml rmFetuB only partially inhibited 
fertilization-triggered ZP hardening, while concentrations higher than 0.03 mg/ml inhibited 
fertilization-triggered ZP hardening completely. As already shown previously, the absence ZP 
hardening did not lead to polyspermy. The fact that fetuin-B supplementation protected 
against ZP hardening, even if fetuin-B was present only until four hours after fertilization 
indicates, that most ovastacin must have been released, but was immediately and efficiently 
inhibited in this relatively short time frame. 
In summary these results indicate that in fetuin-B free medium oocytes underwent premature 
ZP hardening during IVC without surrounding cumulus cells, resulting in a decreased 
fertilization success. The two-cell embryos further underwent fertilization-triggered ZP 
hardening, leading to decreased sperm binding and increased resistance against proteolytic 
ZP digestion. Supplementing HTF with 0.015 mg/ml or more rmFetuB inhibited the premature 
ZP hardening, leading to an increased fertilization success. Concentrations of 0.03 mg/ml 
rmFetuB and higher completely inhibited fertilization-triggered ZP hardening, without 
increasing polyspermy. 
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Figure 25. During in vitro cultivation recombinant murine fetuin-B inhibited ZP hardening and increased 
IVF success. Every dot represents one experimental setup performed with at least 30 oocytes. Light gray 
background indicates mean serum fetuin-B level in Fetub+/- mice and dark gray background indicates mean 
serum fetuin-B level in Fetub+/+ mice. 
 
I already stated that premature ZP hardening manifests within one hour after oocyte isolation 
and removal of the cumulus cells. Furthermore, rmFetuB inhibited premature ZP hardening 
and increased fertilization success. 
In the following experiment I tested for how long rmFetuB is efficient to increase fertilization 
success. Because the inhibition of fertilization-triggered ZP hardening seemed not to have 
any negative effect, I used 0.05 mg/ml. Time lines describing the experimental setup are 
shown in figure 26. COCs were isolated in either fetuin-B free HTF medium, or HTF medium 
containing 0.05 mg/ml rmFetuB. Cumulus cells were removed and oocytes were washed 
three times and pooled. Furthermore I kept the cumulus cells in one condition using fetuin-B 
free medium to see, if they can substitute rmFetuB. Directly or after 1, 5, 9, or 13 hours a 
sample of 20-30 oocytes were taken and sperm were added. Four hours later, zygotes were 
washed in fetuin-B free HTF medium. 24 hours post-fertilization the number of two-cell 
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embryos was counted. Gray sections in figure 26 determine the presence of 0.05 mg/ml 
rmFetuB during IVC. 
 
 
Figure 26. Exemplary illustration of four out of nine timing diagrams used for analyzing the possible 
timeframe for IVC with fetuin-B supplementation. COCs were isolated and cumulus cells were removed. 
Sperm were either added directly or after 1, 5, 9 or 13 hours. After additional four hours potential zygotes were 
washed in fetuin-B free HTF medium. 24 hours post-fertilization the amount of two-cell embryos was quantified. 
Gray section determines the presence of 0.05 mg/ml rmFetuB during incubation. 
 
Figure 27 shows fertilization success after up to 13 hours of IVC following three different 
experimental protocols: 1) IVC after removal of the cumulus cells in HTF medium without 
fetuin-B 2) IVC after removal of the cumulus cells in HTF medium supplemented with 0.05 
mg/ml rmFetuB, and 3) IVC in fetuin-B free HTF medium with cumulus cells present (to 
check for any effect of endogenous fetuin-B stored in the cumulus cell matrix). Figure 27 
shows that 65.1% of oocytes were fertilized in the presence of rmFetuB. When isolated in 
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fetuin-B free HTF medium, 74.9% of oocytes developed into two-cell stages, regardless of 
the presence of cumulus cells. 
In experimental condition 1 (without cumulus cells and without fetuin-B supplementation) 
fertilization success dropped to 20.3% within one hour of IVC, and was further reduced if 
oocytes were cultured for an extended time interval before IVF.  
In experimental condition 2 (without cumulus cells but with supplementation of 0.05 mg/ml to 
HTF medium), 44.1% of the oocytes were fertilized after one hour of IVC. Thus the fetuin-B 
supplementation doubled the fertilization success after one hour of IVC. IVF success and the 
development of two-cell stages was reduced to 25.0% at five hours of IVC, and dropped to 
9,6 % after 13 hours of IVC. Compared to experimental condition 1 one can see, that the use 
of rmFetuB increased the fertilization success at all tested durations of IVC. 
In experimental condition 3 (keeping the cumulus cells, but without fetuin-B supplementation) 
the fertilization success was 33.3%, after one hour of IVC and thus intermediary between the 
two alternative conditions. IVF success remained constant for up to five hours. After nine 
hours of IVC, only 13.0% of oocytes developed to two-cell embryos, and IVF success further 
decreased over time. Compared to experimental condition 1, retention of the cumulus cells 
and thus of endogenous fetuin-B increased fertilization success for up to five hours of IVC. 
Compared to experimental condition 2, supplementation of IVC medium with rmFetuB better 
suited to keep the oocytes fertilizable than was the retention of cumulus cells. 
In conclusion, retention of cumulus cells during IVC increased IVF success for up to five 
hours. The supplementation of HTF medium with 0.05 mg/ml rmFetuB further increased IVF 
success for up to nine hours. Thus the inhibition of premature ZP hardening by cumulus cells 
could indeed be mediated by endogenous fetuin-B stored in the extracellular matrix of these 
cells.  
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Figure 27. The use of recombinant murine fetuin-B during in vitro cultivation increased fertility for up to 
nine hours. IVF was either done in HTF medium without rmFetuB, in HTF medium containing 0.05 mg/ml 
rmFetuB or in HTF medium without rmFetuB but with retention of the cumulus cells. RmFetuB increased 
fertilization success for up to nine hours, while the retention of the cumulus cells increased the number of two-cell 
embryos for up to five hours. 
 
In summary, rmFetuB did not increase fertilization success when sperm was added 
immediately after COC isolation. In contrast, rmFetuB strongly inhibited ZP hardening and 
increased IVF success when cumulus cells were removed, especially when oocytes were 
cultured before IVF for one hour or longer. Fetuin-B at 0.015 mg/ml inhibited premature ZP 
hardening, while 0.03 mg/ml fetuin-B also inhibited fertilization-triggered ZP hardening 
surprisingly not leading to polyspermy. Supplementation of HTF medium with rmFetuB 
increased fertilization success for up to 9 hours of IVC, while retention of the cumulus cells 
similarly kept oocytes fertilizable for 5 hours. 
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4. Discussion 
 
4.1 Fetuin-B Deficient Female Mice are Infertile Due to an Early Block to 
Fertilization 
Quantification of serum samples showed serum concentrations of 161.4  ± 10.5 µg/ml fetuin-
B in Fetub+/+ mice and 89.8 ± 2.8 µg/ml in Fetub+/- mice, respectively. Previous quantitative 
Western blots reported about 300 µg/ml serum fetuin-B in female wildtype mice 2. This 
discrepancy is due to the use of different calibration proteins in various studies. Recombinant 
MBP-fetuin-B fusion protein had been used for calibration, but it was not detailed how the 
protein concentration of this reference was quantified.  A similar study with ten Fetub+/+ adult 
female mice showed fetuin-B serum concentrations of 334 ± 93 µg/ml 18. In this case, 
recombinant murine His-tagged fetuin-B was used to calibrate the quantitative Western blots. 
The concentration of purified His-tagged fetuin-B was determined by measurement of the 
absorbance at 280 nm (A280) with bovine fetuin as the calibration standard. In contrast, 
wildtype females used in the present work only showed half the fetuin-B serum level judged 
against a commercial preparation of recombinant murine fetuin-B (rmFetuB, Invigate) 
employed as the calibration standard in quantitative Western blot. Invigate determined the 
protein concentration of their product by measuring the A280 figuring in a predicted extinction 
coefficient ε280 of 0.572 and a correction factor of 1.4 to for glycosylations. It should be 
noted that the amount estimated by Invigate is reduced by a factor of 2.1 if the protein is 
quantified using the commercial Pierce BCA protein quantification kit and the matching BSA 
calibration standard of 20-2000 µg/ml. Thus reported serum fetuin-B concentrations will vary 
depending on the calibration standard that was used. The estimation of absolute serum 
fetuin-B concentrations and indeed of correct amounts of fetuin-B will become possible once 
a pure fetuin-B preparation has been studied by quantitative amino acid analysis, and a 
correct ε280 has been determined from that preparation. Thus serum fetuin-B concentrations 
measured previously should be nominally 1.7 times higher than reported here, and the 
determination of the “true” amounts awaits confirmation by quantitative amino acid analysis. 
Correcting the serum levels by this factor of 1.7, the Fetub+/+ and Fetub+/- females tested 
here show fetuin-B serum levels of 274.8  ± 17.9 µg/ml and 152.7  ± 4.8 µg/ml, respectively 
which is compatible to the values of 300 µg/ml and 334 µg/ml reported above. Despite the 
discrepancies in absolute values, it was confirmed, that Fetub+/- females have half the fetuin-
B serum levels of Fetub+/+ females. 
Female Fetub-/- mice are completely infertile. Fetub+/- females have half the serum fetuin-B 
level of wildtype animals and reproduce normal. Female infertility of Fetub-/- mice was 
independent of the genetic background and was mediated by an early blockade in 
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fertilization. Fetuin-B deficient oocytes could be fertilized in vitro after overcoming the ZP 
barrier by laser perforation. After embryo transferring to foster mothers, the fetuses 
developed normal. Fetub-/- foster mothers became pregnant, and delivered healthy offspring 
after embryo transfer. Thus the sole reason for infertility in Fetub-/- females is an early 
blockade in fertilization indicating that fetuin-B is critically required before fertilization, but is 
dispensable during later stages of embryonic and fetal live. 
More than 200 genetic mouse models are reported with reproductive defects 162,183. About 50 
show complete female infertility, mostly due to sex hormone disturbance, developmental 
arrest or implantation defects. Fetuin-B adds to this group as a liver-derived non-hormonal 
plasma protein, which is essential for female fertility. In humans, infertility affects about 15% 
of couples worldwide who wish to have children, while both sexes affected to a similar 
degree. The main reasons for female infertility are ovulatory defects, malformations of the 
oviducts or endometriosis. Up to 25% of diagnoses have no apparent pathology, and are 
thus considered idiopathic. Since fetuin-B is well conserved in mammals, abnormalities in the 
FETUB gene could also lead to loss of function of the human fetuin-B protein and thus to 
female infertility. The genome project lists more than 4600 variations in the human fetuin-B 
gene, multiple splice variants and more than 330 sequence variants for FETUB, that change 
one or more bases, resulting in a different amino acid sequence but with preserved length 
(http://browser.1000genomes.org/Homo_sapiens/Gene/Variation_Gene/Table?db=core;g=E
NSG00000090512;r=3:186353758-186370930). This unusually strong polymorphism argues 
against a gene conservation, which would be expected if fetuin-B was sensitive to mutations. 
Clearly, a loss of fetuin-B function would result in an evolutionary disadvantage and 
counterselection. Therefore the high number of mutations seems counterintuitive. 
Nevertheless, any or all of them might potentially affect the function of human fetuin-B 
protein. For lack of knowledge about the structure-function relationship, we do not know, if 
any of these variants are indeed functionally relevant. Thus the study of fetuin-B is not only 
an interesting topic of reproductive medicine, but also from an evolutionary point of view. 
 
4.2 Fetuin-B Deficient Oocytes Undergo Premature Zona Pellucida Hardening 
We showed that premature ZP hardening concurred with ovulation and blocked fertilization of 
fetuin-B deficient oocytes. Until now, premature ZP hardening was only known from in vitro 
oocyte culture and fertilization 71,145. Fetuin-B deficient mice are the first reported example of 
premature ZP hardening in vivo. Because spontaneous ZP hardening during in vitro culture 
is also reported in humans, alterations in the FETUB gene could also lead to premature ZP 
hardening in vivo 71. One would predict, that IVF should fail in the absence of functional 
fetuin-B because of blocked oocyte-sperm binding. A study of Liu and Baker showed that 
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about 6% of failed IVF with low sperm-ZP interactions had normal sperm morphology, and 
thus could be due to defects of the ZP 184. Considering that about 15% of the couples 
worldwide are infertile and that up to 30% of IVF fail this would mean that 0.27 % (0.06 x 
0.15 x 0.30) of the women worldwide eventually show ZP defects. This amount seems very 
low, but it has to be mentioned that the amount of women, showing premature ZP hardening 
would be expected to be very low until today, since females with a fetuin-B defect would not 
have been able to reproduce until ART and especially ICSI was investigated in the 1990th. In 
the next decades the amount of females carrying fetuin-B mutations could increase since the 
heredity will be promoted by the use of ARTs. Thus also the amount of infertile women will 
increase. For patients, who fail in IVF treatment, intracytoplasmatic sperm injection (ICSI) is 
used nowadays to overcome the ZP barrier, both at higher costs and considerable loss of the 
number of implantable embryos 184. Addition of fetuin-B to oocytes at the earliest 
convenience might improve IVF success in humans with defects in the FETUB gene. The 
block of premature ZP hardening in theses patients by medication with fetuin-B derivates 
could even allow in vivo fertilization, avoiding previous hormonal stimulation and the 
associated risks. 
Earlier reports showed, that FCS as well as bovine fetuin inhibit premature ZP hardening in 
vitro 148,154,155. First assumptions that fetuin-A was the factor inhibiting ZP hardening were not 
confirmed. We could show that both, FCS and bovine fetuin, contain fetuin-B. Thus fetuin-B 
rather than fetuin-A inhibited ZP hardening in earlier studies. 
In all the shown experiments to check ZP hardening, two-cell embryos obtained by IVF were 
used as controls and surprisingly showed less ZP hardening compared to fetuin-B deficient 
oocytes. We hypothesized that this is due to endogenous fetuin-B that is stored at the 
extracellular matrix of the cumulus cells. Denecke et al. showed that fetuin-B expression is 
absent in mice ovaries but that fetuin-B is probably located in the extracellular matrix 2. This 
suggests the assumption that fetuin-B diffuses out of the blood into the follicular fluid at 
antrum formation like it was already proposed for other proteins 157,185,186. There it invades 
into the extracellular matrix of the cumulus cells whereby it reaches the oocyte. It was shown 
that the cumulus cell matrix is mainly composed of hyaluronic acid, but also composes serum 
maintained components, that are linked to the extracellular matrix by cumulus cell derived 
factors 187–191. As for the mode of action we suggest that fetuin-B of 55 - 60 kDa can freely 
diffuse through the ZP, which is permeable for molecules up to 150 kDa 39. Thus fetuin-B can 
readily antagonize the proteolytic action of prematurely released ZP2 protease ovastacin 
during oocyte maturation. Following ovulation and COC penetration the extracellular matrix is 
digested by sperm specific proteases to loose cumulus cells and thus make the oocyte 
accessible, also leading to a decrease of surrounding fetuin-B. Furthermore the developing 
embryo is transported through the oviduct to the uterus, which could add to the decrease in 
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surrounding fetuin-B concentration. Following fertilization and degranulation of the cortical 
granula, the amount of ZP2 protease ovastacin will overwhelm the inhibition capacity of 
fetuin-B, which is in steady state with plasma fetuin-B, but does not increase upon 
fertilization. As a consequence in vivo premature ZP hardening would be inhibited to 
maintain fertility, while fertilization-triggered ZP hardening would not be inhibited. At IVF the 
penetrating sperm remove cumulus cells as well, but in contrast to in vivo fertilization, the 
cumulus cells and their extracellular environment stay around the oocyte due to the limited 
space. Thus in vitro the dilution of fetuin-B would be less compared to the in vivo conditions. 
As a consequence premature ZP hardening would be inhibited in vitro only temporary. 
Fetuin-B diffuses out of the cumulus cell matrix with time, leading to fetuin-B dilution in the 
direct environment of the oocyte. Thus with progressive time the ZP hardens prematurely. 
After in vitro fertilization the amount of released ovastacin increases like in vivo while the 
surrounding fetuin-B is in steady state and does not decrease like in vivo, leading only to 
partial fertilization-triggered ZP hardening. At fetuin-B deficiency inhibition of premature ZP 
hardening is lost, leading to infertility. 
 
4.3 Fetuin-B Inhibits Ovastacin and Thus Zona Pellucida Hardening 
To elucidate the molecular mechanism of ZP hardening inhibition by fetuin-B, we turned to 
proteases, because fetuins belong to the cystatin superfamily, a group of thiol protease 
inhibitors 1. Early studies employing golden hamster oocytes showed that ZP hardening is 
triggered by the release of cortical granule material including proteases. Prompted by a 
recent report, which showed that the cortical granula metalloproteinase ovastacin cleaves 
ZP2, triggering definitive ZP hardening, we studied the molecular interaction of recombinant 
fetuin-B protein with ovastacin 122. Indeed, recombinant fetuin-B inhibited recombinant 
ovastacin at concentrations fully compatible with the measured fetuin-B plasma and follicular 
fluid concentrations.  
As already mentioned plasmin was also discussed to trigger ZP hardening, but the molecular 
mechanism behind these observations could not be clarified until today 118,192. Interestingly 
plasmin is known to activate metalloproteases. As ovastacin is classified as a 
metalloprotease and is expressed as a propeptide it could be possible, that plasmin activates 
ovastacin 193,194. Thus the noticed effect of plasmin to increase ZP hardening could be 
indirect 51. Probably pro-ovastacin is released by the cortical granules and is activated in the 
perivitelline space by plasmin, eventually giving a new level of ZP hardening regulation 195,196. 
It was shown that oviductal fluid contains about 90 µg/ml plasminogen and thus surrounds 
the oocyte at least after ovulation 118. Plasminogen was further detected at the oolemma and 
the ZP.  Plasminogen activators are located at the oolemma as well and are further released 
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by the oocyte and the sperm after gamete interaction and fertilization 118,119. Thus low 
concentrations of active plasmin are already present during oocyte maturation and increases 
after fertilization 118. Plasmin could then cleave pro-ovastacin leading to activation of 
ovastacin that cleaves ZP2 to induce ZP hardening. In humans plasminogen mutations 
correlate with subfertility, while mice deficient for either plasminogen or plasminogen 
activators are fertile 120,121,197. Thus the role of the plasminogen / plasminogen activator / 
plasmin seems to be species specific and eventually adds to the regulation of ZP hardening 
by ovastacin activation, but also seems to be compensable. 
Fetuins are known to be potent protease inhibitors. Already in the 1970 Galembeck and 
colleagues described bovine fetuin as a trypsin inhibitor, not discriminating between fetuin-A 
and fetuin-B 198. Subsequent publications used the known trypsin inhibitor function of bovine 
fetuin to explain the inhibitory potency in ZP hardening 152,154,155. In these study they used 
purified bovine fetuin, that we now know can contain both fetuins. Human preparations 
enriched for fetuin-A do not have anti-proteolytic activity or inhibit ZP hardening 152,199. 
Furthermore results of experiments with recombinant fetuin-A lead to the suggestion that the 
trypsin specific anti-proteolytic activity associated with conventionally purified bovine fetuin 
may be due to a copurifying contaminant 200. Other studies showed comparable results. 
Meprin α and β, two zinc metalloproteinases were also shown to be inhibited by purified 
human and bovine fetuin, while recombinant human fetuin-A only inhibited meprin β 201. Thus 
the anti-proteolytic activity of purified bovine or human fetuin to several proteases, like trypsin 
and meprin β, could also be mediated by fetuin-B. Ongoing studies at the lab of professor 
Walter Stöcker (Mainz) with the use of recombinant murine fetuin-A and fetuin-B seem to 
confirm this assumption. Thus it is easily conceivable that fetuin-B has further functions 
beside the here shown inhibition of premature ZP hardening, even if the Fetub-/- mice 
showed no obvious defect beside the female infertility. 
 
4.4 Fetuin-B Increases Fertilization Success in Vitro 
The supplementation of IVF medium with recombinant murine fetuin-B had no effect on 
fertilization success, when sperm was added immediately after COC isolation. After cumulus 
cell removal and one hour of in vitro cultivation rmFetuB inhibited ZP hardening and 
increased IVF success.  Less than 0.015 mg/ml inhibited premature ZP hardening while 0.03 
mg/ml further inhibited fertilization-triggered ZP hardening, surprisingly not leading to 
polyspermy. Supplementation of HTF medium with rmFetuB increased fertilization success 
for up to nine hours of in vitro cultivation, while retention of the cumulus cells showed similar 
results. 
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Earlier studies showed comparable results of FCS and bovine fetuin as described in the 
present work for rmFetuB. It is known that FCS and bovine fetuin comprise both, fetuin-A and 
fetuin-B, but unfortunately proportional distribution is not known. Thus results of the present 
work can only be compared with results of earlier studies to make a rough estimate about the 
amount of fetuin-B that is contained in FCS or purified bovine fetuin. With an amount of 10-
20 mg/ml, fetuins are the most abundant constituent of FCS 202. Early studies used 5-20% 
FCS resulting in 0.5-4 mg/ml fetuin. These predicted concentrations were assumed by the 
fact that 20% FCS was effective as 3-5 mg/ml purified bovine fetuin in inhibiting ZP 
hardening 152. Schröder and colleagues showed, that with the use of 1 mg/ml purified bovine 
fetuin, the inhibitory capacity is already reduced and using 0.1 mg/ml bovine fetuin the 
relative ZP hardening already doubles, compared to 5% FCS (depicting 0.5-1 mg/ml bovine 
fetuin) 155. Comparing the results of Schröder et al. and the data of the present work, 1 mg/ml 
bovine fetuin showed similar results to 0.015 mg/ml rmFetuB. Leaving out of account species 
specific variations of fetuin-B activity one could predict that bovine fetuin comprises about 
1.5% of fetuin-B. As already mentioned before FCS, human serum or purified products of 
serum are general used in cell culture as a protein source, but with a risk of infections and 
LOT-to-LOT variations 149,203. Thus the long-term goal at in vitro cultivation and fertilization is 
the replacement of serum-derived additives by recombinant expressed proteins. To realize 
this intention 0.015 mg/ml rmFetuB could replace the inhibitory effect on ZP hardening of 1 
mg/ml bovine fetuin or 5% FCS. 
After fertilization ZP hardening is thought to block polyspermy. Controversial the use of 
fetuin-B during IVF procedure inhibited fertilization-triggered ZP hardening, but did not 
increase polyspermy. Thus fertilization-triggered changes at the membrane level seem to be 
efficient to inhibit polyspermy. Furthermore ZP hardening would not be necessary for an 
efficient polyspermy block, but eventually still for protecting the embryo until implantation. 
Ovastacin deficient mice (Astl-/-) as well as mice that were mutated in the ZP2 cleavage site 
(Zp2mut/mut) both lack ZP hardening 97,122. Zp2mut/mut females show smaller litter sizes 97. After 
spontaneous mating and in vivo fertilization the number of one-cell embryos was comparable 
to wildtypes. There was no evidence of supernumerary sperm in the perivitelline space. 
Instead the ZP was thinner compared to wildtype oocytes and the amount of flushed 
blastocysts at day 3.5 post-fertilization was decreased. Thus, early embryonic loss probably 
due to premature ZP hatching appears as the major contributor to the subfertility observed in 
Zp2mut/mut females. Ovastacin deficient mice show decreased fertility, but polyspermy was not 
shown, only predicted 122. Thus subfertility of Astl-/- females could also be mediated by early 
embryo loss like described for the Zp2mut/mut mice. Our findings, that inhibition of fertilization-
triggered ZP hardening by fetuin-B does not result in polyspermy, support the idea that an 
effective post-fertilization block to polyspermy is independent of ZP2 cleavage. 
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The present data show that retention of cumulus cells at IVF had similar effects on premature 
ZP hardening than the addition of fetuin-B to the IVF medium. As a consequence one could 
say that the fetuin-B supplementation of IVF medium would be redundant. But this is only 
true for IVF treatments that are done under optimal conditions, meaning active endogenous 
fetuin-B detained at the cumulus cell matrix and fertilization immediately after COC isolation. 
But also at these condition one would agree, that the use of fetuin-B was not 
counterproductive, since fetuin-B neither increased polyspermy nor decreased embryo 
development. In contrast under suboptimal conditions, meaning decreased fetuin-B activity 
or even completely loss of fetuin-B (simulated by cumulus cell removal) or increased duration 
until fertilization, the addition of fetuin-B to IVF medium can increase fertilization success. 
Thus even if fetuin-B supplementation might not improve fertilization success in all IVF 
cases, the use of fetuin-B in IVF medium makes sense until the need is not tested before 
each IVF treatment. 
Beside the probably benefit of fetuin-B to human reproductive medicine, fetuin-B could also 
have an impact on mouse research, factory farming or IVF of other animals. As shown in the 
present work for C57BL/6 mice the supplementation of IVF medium with fetuin-B could be 
redundant, if IVF is done under optimal condition. But to visualize different processes in the 
oocyte, especially during fertilization, the cumulus cells often have to be removed. In this 
case the use of fetuin-B can improve results. Furthermore there are several mouse strains, 
which show decreased IVF success, caused by premature ZP hardening. For example the 
IVF success of the inbreed mouse strain 129S1/SvlmJ is less than 25% 173. KE mice also 
perform low success at IVF and oocytes isolated from these mice showed higher resistance 
against proteolytic ZP digestion by chymotrypsin 204. At the use of these mouse strains the 
supplementation of fetuin-B would event be more sensible, compared to C57BL/6 mice, used 
in this work.  
In diary and meat industry IVF is used to achieve the ability to provide food for an ever-
expanding world population 205. The most productive animals are selected to be donors for 
IVF and less productive females are used as embryo recipient 206. Thus the reproduction rate 
of profitable animals can be increased drastically. Furthermore sperm sorting by flow 
cytometry is used to influence offspring gender, for example to get more dairy cows 207. In 
2012 about 0.9 Mio embryos were transferred in cattle worldwide 208. The use of IVF for other 
farm animals is less (23000 ovine; 15000 equine and 2500 porcine embryos worldwide in 
2012), but is constantly crowing, indicating the high commercial use of IVF in livestock 
farming. At assisted reproduction it was shown that fetuin prevents ZP hardening in horses 
209. In bovine IVF premature ZP hardening reduces fertilization success and the use of fetuin 
increased the amount of blastocysts 204,210,211. As a general consequence the use of 
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recombinant fetuin-B could increase IVF success in farm animals as well and thus should be 
of high commercial interest.  
With growing global population the natural environment available for wild animals decreases 
and thus the number of endangered species increases. For endangered animals showing 
small populations, ARTs and especially IVF are the best way to produce a high number of 
offspring from selected donors. A good example of ART application in wild animals is the 
European mouflon. Ptak et al. demonstrated for the first time the potential of IVF to rescue an 
endangered species, the European mouflon, with substantial yields of oocytes, embryos and 
pregnancy, independent of age and breeding season 212. In other endangered species, for 
example non-human primates, oocyte in vitro maturation was improved by bovine fetuin, 
giving a new potential application for fetuin-B 156. Embryos that are not used directly for 
transfer are often preserved by freezing, called cryopreservation. Cryopreserved embryos 
can be stored over decades and thus genetic diversity can be preserve 213,214. Several 
specialized centers have been established that cryopreserve tissue from valuable, rare, and 
endangered species 215,216. Reproductive tissue of highly diverse species already is 
preserved, for example the polar bear, chimpanzees, south American bush dogs, gorillas, 
Mexican wolves, Mongolian wild horses and orangutans. It was shown that cryopreservation 
of oocytes leads to spontaneous release of cortical granules and to ZP hardening 217. Thus 
the improvement of cryopreservation and IVF, done with endangered animals, can be a 
further scope of application for fetuin-B to retain these species. 
In humans embryos are cryopreserved after assisted reproduction for later implantation as 
well. In the last years furthermore oocyte cryopreservation has increased for several reasons 
218. Females diagnosed with cancer can safe the oocytes against damages triggered by 
chemotherapy or radiotherapy. In some other cases females undergo ART, not considering 
embryo but oocyte freezing an option. In other cases of oocyte cryopreservation there are 
females who would like to preserve their future ability to have children, either because they 
do not yet have a partner, or for other personal or medical reasons. In these cases oocytes 
are cryopreserved for later use in ART. As it was already mentioned, oocyte cryopreservation 
leads to premature ZP hardening. Thus the use of fetuin-B during freezing procedure can 
inhibit ZP hardening and the oocytes can be fertilized by IVF after thawing 149,217,219. 
Coming back to the shown data, where endogenous cumulus cell retained fetuin-B showed 
similar results as supplemented recombinant fetuin-B, it is further important to mention that 
the experiments presented in this work were done with ovulated oocytes. It is known that the 
most spontaneous released cortical granules are exocytosed during germinal vesicle 
breakdown that starts before ovulation. Thus a certain proportion of premature released 
ovastacin was probably already inhibited by endogenous fetuin-B. To isolate several human 
oocytes females are typically hormonal stimulated for ovulation to induce oocytes maturation. 
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Afterwards the COCs are obtained by follicle puncture before ovulation and not as typically 
done for mice, where COCs are isolated out of the ampulla after ovulation. Thus it is possible 
that for human oocytes at IVF treatment the major amount of spontaneous cortical granula 
release happens in vitro and not in vivo like in mice. Thus the addition of recombinant fetuin-
B to IVF medium would have a more obvious impact than shown in this work. For women 
with eventually FETUB defects the recent work shows that the oocytes should either be 
isolated before they undergo premature ZP hardening or the oocytes should be fertilized by 
overcoming the ZP as a barrier (for instance by laser assisted IVF or intracytoplasmatic 
sperm injection ICSI). Thus the screening of infertile women for FETUB defects could help to 
decide which kind of ART would be the best. Further thinking it would be possible to spare 
these females the necessity of ART, if the premature ZP hardening could be inhibited 
probably by treatment with fetuin-B derivates. 
 
- Conclusion and Future Aspects - 
76 
Conclusion and Future Aspects 
 
Fetuin-B inhibits spuriously released 
ovastacin, either in vivo or in vitro, and thus 
maintains ZP permeability (figure 28). After 
fertilization, ovastacin concentration 
suddenly increases following degranulation 
of the cortical granula, overwhelming the 
inhibition capacity of fetuin-B, resulting in 
ZP2 cleavage and ultimately, ZP hardening. 
The fertilization-triggered polyspermy 
blockade seems to be independent of ZP 
hardening, while ZP hardening is important 
for protecting the pre-implantation embryo. In 
fetuin-B deficiency, either in vivo or in vitro, 
ZP hardens during maturation, which blocks 
fertilization. Thus fetuin-B represents an 
therapeutic target for fertilization biology and 
reproductive medicine.  
Identifying functional defects in the human FETUB gene may explain hitherto “idiopathic” 
cases of female infertility. Supplementation of oocyte culture medium with recombinant 
fetuin-B could increase IVF success in several species by inhibiting premature ZP hardening. 
Fetuin-B may also obviate the damage inflicted to oocytes by established methods 
overcoming the ZP e.g. ICSI. In addition, fetuin-B may be used to inhibit fertilization-triggered 
ZP hardening to assist hatching without the embryo damage inflicted e.g. by ZP laser 
perforation or by partial ZP dissection. On a practical note, the regulation of female fertility 
through plasma fetuin-B may be exploited for a non-hormonal contraceptive therapy aiming 
at reducing serum fetuin-B below the critical values required for the inhibition of premature 
ZP hardening. 
 
Figure 28. Illustration of the biological function 
of fetuin-B. (top) During oocyte maturation fetuin-B 
retains ZP permeability. (bottom) Fetuin-B deficiency 
leads to premature ZP hardening and female 
infertility. 
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ADAM  a disintegrin and metalloproteinase 
AHSG  α2-HS-glycoprotein gene, human fetuin-A gene 
AHSG  α2-HS-glycoprotein, human fetuin-A protein 
AMH  anti-müllerian hormone 
Astl  murine Ovastacin gene 
ASTL  human Ovastacin gene 
BMP4  bone morphogenetic protein-4 
BMP7  bone morphogenetic protein-7 
BMP8b bone morphogenetic protein-8b 
BMP15 bone morphogenetic protein-15 
BSA  bovine serum albumin 
cAMP  cyclic adenosine monophosphate 
COC  cumulus-oocyte complex 
CSF  cytostatic factor 
DNA  deoxyribonucleic acid 
ECL  electrogenerated chemiluminescence 
EDTA  ethylenediaminetetraacetic acid 
FCS  fetal calf serum 
FetuA  murine fetuin-A gene 
FetuA  fetuin-A protein 
Fetub  murine fetuin-B gene 
FETUB human fetuin-B gene 
FetuB  fetuin-B protein 
FSH  follicle stimulating hormone 
FXR  farnesoid X receptor 
GDF9  growth and differentiation factor-9 
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hCG  human chorionic gonadotropin 
HK  high molecular weight kininogen 
HRG  histidine rich glycoprotein 
HRP  horseradish peroxidase 
HSA  human serum albumin 
HTF  human tubular fluid 
ICM  inner cell mass 
IVC  in vitro cultivation 
IVF  in vitro fertilization 
IU  international units 
kb  kilobase 
kDa  kilodalton 
KNG  kininogen 
LH  luteinizing hormone 
LIF  leukemia inhibitory factor 
LK  low molecular weight kininogen 
MBCD  metyl-beta-cyclodextrin 
MPF  maturation promoting factor 
OGP  oviduct-specific glycoprotein 
PAGE  polyacrylamide gel electrophoresis 
PBS  phosphate buffered saline 
PBST  phosphate buffered saline with 0.05% Tween20 
PFA  paraformaldehyde 
rmFetuB recombinant murine fetuin-B 
RNA  ribonucleic acid 
SCF  stem cell factor 
SDS  sodium dodecyl sulfate 
TBST  TRIS buffered saline with 0.05% Tween20 
TE  trophectoderm 
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TEPs  trophectodermal projections 
TGF-β  transforming growth factor β 
TRIS  tris(hydroxymethyl)aminomethane 
ZP  zona pellucida 
Zp1  murine zona pellucida protein 1 gene 
ZP1  human zona pellucida protein 1 gene 
ZP1  zona pellucida protein 1 
Zp2  murine zona pellucida protein 2 gene 
ZP2  human zona pellucida protein 2 gene 
ZP2  zona pellucida protein 2 
Zp3  murine zona pellucida protein 3 gene 
ZP3  human zona pellucida protein 3 gene 
ZP3  zona pellucida protein 3 
Zp4  murine zona pellucida protein 4 gene 
ZP4  human zona pellucida protein 4 gene 
ZP4  zona pellucida protein 4 
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mZp1    PGFEYSYDCGVRGMQLLVFPRPNQTVQFKVLDEFGNRFEVNNCSICYHWVTSEAQEHTVF  86 
hZp1    PGLRHSYDCGIKGMQLLVFPRPGQTLRFKVVDEFGNRFDVNNCSICYHWVTSRPQEPAVF  94 
 
mZp1    SADYKGCHVLEKDGRFHLRVFIQAVLPNGRVDIAQDVTLICPKPDHTVTPDPYLAPPTTP  146 
hZp1    SADYRGCHVLEKDGRFHLRVFMEAVLPNGRVDVAQDATLICPKPDPSRTLDSQLAPPAMF  154 
 
mZp1    EPFTPHAFALHPIPDHTLAGSGHTGLTTLYPEQSFIHPTPAPPSLGPGPAGSTVPHSQWG  206 
hZp1    SVSTPQTLSFLPTSGHTSQGSGHAFPSPLDPGHSSVHPTPALPSPGPGPTLATLAQPHWG  214 
 
mZp1    TLEPWELTELDSVGTHLPQERCQVASGHIPCMVNGSSKEACQQAGCCYDSTKEEPCYYGN  266 
hZp1    TLEHWDVNKRDYIGTHLSQEQCQVASGHLPCIVRRTSKEACQQAGCCYDNTREVPCYYGN  274 
 
mZp1    TVTLQCFKSGYFTLVMSQETALTHGVLLDNVHLAYAPNGCPPTQKTSAFVVFHVPLTLCG  326 
hZp1    TATVQCFRDGYFVLVVSQEMALTHRITLANIHLAYAPTSCSPTQHTEAFVVFYFPLTHCG  334 
 
mZp1    TAIQVVGEQLIYENQLVSDIDVQKGPQGSITRDSAFRLHVRCIFNASDFLPIQASIFSPQ  386 
hZp1    TTMQVAGDQLIYENWLVSGIHIQKGPQGSITRDSTFQLHVRCVFNASDFLPIQASIFPPP  394 
 
mZp1    PPAPVTQSGPLRLELRIATDKTFSSYYQGSDYPLVRLLREPVYVEVRLLQRTDPSLVLLL  446 
hZp1    SPAPMTQPGPLRLELRIAKDETFSSYYGEDDYPIVRLLREPVHVEVRLLQRTDPNLVLLL  454 
 
mZp1    HQCWATPTTSPFEQPQWPILSDGCPFKGDNYRTQVVAADKEALPFWSHYQRFTITTFMLL  506 
hZp1    HQCWGAPSANPFQQPQWPILSDGCPFKGDSYRTQMVALDG-ATPFQSHYQRFTVATFALL  513 
 
mZp1    DSSSQNALRGQVYFFCSASACHPLGSDTCSTTCDSGIARRRRSSGHHNITLRALDIVSSP  566 
hZp1    DSGSQRALRGLVYLFCSTSACHTSGLETCSTACSTGTTRQRRSSGHRNDTARPQDIVSSP  573 
 
mZp1    GAVGFEDAAKLE----PSGSSRNSSSRMLLLLLAITLALAA----GIFVGLIWAWAQKLW  618 
hZp1    GPVGFEDSYGQEPTLGPTDSNGNSSLRPLLWAVLLLPAVALVLGFGVFVGLSQTWAQKLW  633 
 
mZp1    EGIR  622 
hZp1    ESNR  637 
 
 
Figure S1. Alignment of murine (m) and human (h) Zp1 coding sequence, showing 68% identical and 77% 
similar amino acids. Species are noted on the left. Similar residues conserved in the two sequences are printed 
as white letters on black background. A minimum number of gaps, indicated by hyphens, has been introduced to 
maximize alignments. Alignments were produced using the web based alignment service BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and default parameters (blastp algorithm, BLOSUM62 Matrix, Gap Cost 
existence:11 extention:1, conditional compositional score matrix adjustment). 
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mZp2    MARWQRKASVSSP----CGRSIYRFLSLLFTLVTSVNSVSLPQSENPAFPGTLICDKDEV  56 
hZp2    MACRQRGGSWSPSGWFNAGWSTYRSISLFFALVTSGNSIDVSQLVNPAFPGTVTCDEREI  60 
 
mZp2    RIEFSSRFDMEKWNPSVVDTLGSEILNCTYALDLERFVLKFPYETCTIKVVGGYQVNIRV  116 
hZp2    TVEFPSSPGTKKWHASVVDPLGLDMPNCTYILDPEKLTLRATYDNCTRRVHGGHQMTIRV  120 
 
mZp2    GDTTTDVRYKDDMYHFFCPAIQAE-THEISEIVVCRRDLISFSFPQLFSRLADENQNVS-  174 
hZp2    MNNSAALRHGAVMYQFFCPAMQVEETQGLSASTICQKDFMSFSLPRVFSGLADDSKGTKV  180 
 
mZp2    EMGWIVKIGNGTRAHILPLKDAIVQGFNLLIDSQKVTLHVPANATGIVHYVQESSYLYTV  234 
hZp2    QMGWSIEVGDGARAKTLTLPEAMKEGFSLLIDNHRMTFHVPFNATGVTHYVQGNSHLYMV  240 
 
mZp2    QLELLFSTTGQKIVFSSHAICAPDLSVACNATHMTLTIPEFPGKLESVDFGQWSIPEDQW  294 
hZp2    SLKLTFISPGQKVIFSSQAICAPD-PVTCNATHMTLTIPEFPGKLKSVSFENQNIDVSQL  299 
 
mZp2    HANGIDKEATNGLRLNFRKSLLKTKPSEKCPFYQFYLSSLKLTFYFQGNMLSTVIDPECH  354 
hZp2    HDNGIDLEATNGMKLHFSKTLLKTKLSEKCLLHQFYLASLKLTFLLRPETVSMVIYPECL  359 
 
mZp2    CESPVSI--DELCAQDGFMDFEVYSHQTKPALNLDTLLVGNSSCQPIFKVQSVGLARFHI  412 
hZp2    CESPVSIVTGELCTQDGFMDVEVYSYQTQPALDLGTLRVGNSSCQPVFEAQSQGLVRFHI  419 
 
mZp2    PLNGCGTRQKFEGDKVIYENEIHALWENPPSNIVFRNSEFRMTVRCYYIRDSMLLNAHVK  472 
hZp2    PLNGCGTRYKFEDDKVVYENEIHALWTDFPPSKISRDSEFRMTVKCSYSRNDMLLNINVE  479 
 
mZp2    GHPSPEAFVKPGPLVLVLQTYPDQSYQRPYRKDEYPLVRYLRQPIYMEVKVLSRNDPNIK  532 
hZp2    SLTPPVASVKLGPFTLILQSYPDNSYQQPYGENEYPLVRFLRQPIYMEVRVLNRDDPNIK  539 
 
mZp2    LVLDDCWATSSEDPASAPQWQIVMDGCEYELDNYRTTFHPAGSSAAHSGHYQRFDVKTFA  592 
hZp2    LVLDDCWATSTMDPDSFPQWNVVVDGCAYDLDNYQTTFHPVGSSVTHPDHYQRFDMKAFA  599 
 
mZp2    FVSEARGLSSLIYFHCSALICNQVSLDSPLCSVTCPASLRSKRE--ANKEDTMTVSLPGP  650 
hZp2    FVSEAHVLSSLVYFHCSALICNRLSPDSPLCSVTCPVSSRHRRATGATEAEKMTVSLPGP  659 
 
mZp2    ILLLSDVSSSKGV------------DPSSSEITKDI------------IAKDIASKTLGA  686 
hZp2    ILLLSDDSSFRGVGSSDLKASGSSGEKSRSETGEEVGSRGAMDTKGHKTAGDVGSKAVAA  719 
 
mZp2    VAALVGSAVILGFICYLYKKRTIRFNH  713 
hZp2    VAAFAGVVATLGFIYYLYEKRTVS-NH  745 
 
 
Figure S2. Alignment of murine (m) and human (h) Zp2 coding sequence, showing 58% identical and 72% 
similar amino acids. Species are noted on the left. Similar residues conserved in the two sequences are printed 
as white letters on black background. A minimum number of gaps, indicated by hyphens, has been introduced to 
maximize alignments. Alignments were produced using the web based alignment service BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and default parameters (blastp algorithm, BLOSUM62 Matrix, Gap Cost 
existence:11 extention:1, conditional compositional score matrix adjustment). 
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mZp3    MASSYFLFLCLLLCGGPELCNSQTLWLLPGGTPTPVGSSSPVKVECLEAELVVTVSRDLF  60 
hZp3    MELSYRLFICLLLWGSTELCYPQPLWLLQGGASHPETSVQPVLVECQEATLMVMVSKDLF  60 
 
mZp3    GTGKLVQPGDLTLGSEGCQPRVSVDT-DVVRFNAQLHECSSRVQMTKDALVYSTFLLHDP  119 
hZp3    GTGKLIRAADLTLGPEACEPLVSMDTEDVVRFEVGLHECGNSMQVTDDALVYSTFLLHDP  120 
 
mZp3    RPVSGLSILRTNRVEVPIECRYPRQGNVSSHPIQPTWVPFRATVSSEEKLAFSLRLMEEN  179 
hZp3    RPVGNLSIVRTNRAEIPIECRYPRQGNVSSQAILPTWLPFRTTVFSEEKLTFSLRLMEEN  180 
 
mZp3    WNTEKSAPTFHLGEVAHLQAEVQTGSHLPLQLFVDHCVATPSPLPDPNSSPYHFIVDFHG  239 
hZp3    WNAEKRSPTFHLGDAAHLQAEIHTGSHVPLRLFVDHCVATPTP--DQNASPYHTIVDFHG  238 
 
mZp3    CLVDGLSESFSAFQVPRPRPETLQFTVDVFHFANSSRNTLYITCHLKVAPANQIPDKLNK  299 
hZp3    CLVDGLTDASSAFKVPRPGPDTLQFTVDVFHFANDSRNMIYITCHLKVTLAEQDPDELNK  298 
 
mZp3    ACSFNKTSQSWLPVEGDADICDCCSHGNCSNSSSSQFQIHGPRQWSKLVSRNRRHVTDEA  359 
hZp3    ACSFSKPSNSWFPVEGPADICQCCNKGDCGTPSHSRRQPHVMSQWSRSASRNRRHVTEEA  358 
 
mZp3    DVTVGPLIFLGKANDQTVEGWTASAQTSVA-LGLGLATVAFLTLAAIVLAVTRKCHSSSY  418 
hZp3    DVTVGPLIFLDRRGDHEVEQWALPSDTSVVLLGVGLAVVVSLTLTAVILVLTRRCRTASH  418 
 
mZp3    LVS  421 
hZp3    PVS  421 
 
 
Figure S3. Alignment of murine (m) and human (h) Zp3 coding sequence, showing 68% identical and 77% 
similar amino acids. Species are noted on the left. Similar residues conserved in the two sequences are printed 
as white letters on black background. A minimum number of gaps, indicated by hyphens, has been introduced to 
maximize alignments. Alignments were produced using the web based alignment service BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and default parameters (blastp algorithm, BLOSUM62 Matrix, Gap Cost 
existence:11 extention:1, conditional compositional score matrix adjustment). 
 
 
 
hZp4    MWLLRCVLLCVSLSLAVSGQHKPEAPDYSSVLHCGPWSFQFAVNLNQEATSPPVLIAWDN 
 
hZp4    QGLLHELQNDSDCGTWIRKGPGSSVVLEATYSSCYVTEWDSHYIMPVGVEGAGAAEHKVV 
 
hZp4    TERKLLKCPMDLLARDAPDTDWCDSIPARDRLPCAPSPISRGDCEGLGCCYSSEEVNSCY 
 
hZp4    YGNTVTLHCTREGHFSIAVSRNVTSPPLLLDSVRLALRNDSACNPVMATQAFVLFQFPFT 
 
hZp4    SCGTTRQITGDRAVYENELVATRDVKNGSRGSVTRDSIFRLHVSCSYSVSSNSLPINVQV 
 
hZp4    FTLPPPFPETQPGPLTLELQIAKDKNYGSYYGVGDYPVVKLLRDPIYVEVSILHRTDPYL 
 
hZp4    GLLLQQCWATPSTDPLSQPQWPILVKGCPYIGDNYQTQLIPVQKALDLPFPSHHQRFSIF 
 
hZp4    TFSFVNPTVEKQALRGPVHLHCSVSVCQPAETPSCVVTCPDLSRRRNFDNSSQNTTASVS 
 
hZp4    SKGPMILLQATKDPPEKLRVPVDSKVLWVAGLSGTLILGALLVSYLAVKKQKSCPDQMCQ 
 
 
Figure S3. Human (h) Zp4 coding sequence. Since Zp4 is not translated in mice, no alignment was accessible. 
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mAstl    MGSLWPWILTMLSLLGLSMGAPSASRCSGVCSTSVPEGFTPEGSPVFQDKDIPAINQGLI  63 
hAstl    VGGLWPWVLGLLSLPGVILGAPLASSCAGACGTSFPDGLTPEGTQASGDKDIPAINQGLI  63 
 
mAstl    SEETPESSFLVEGDIIRPSPFRLLSVTNNKWPKGVGGFVEIPFLLSRKYDELSRRVIMDA  123 
hAstl    LEETPESSFLIEGDIIRPSPFRLLSATSNKWPMGGSGVVEVPFLLSSKYDEPSRQVILEA  123 
 
mAstl    FAEFERFTCIRFVAYHGQRDFVSILPMAGCFSGVGRSGGMQVVSLAPTCLRKGRGIVLHE  183 
hAstl    LAEFERSTCIRFVTYQDQRDFISIIPMYGCFSSVGRSGGMQVVSLAPTCLQKGRGIVLHE  183 
 
mAstl    LMHVLGFWHEHSRADRDRYIQVNWNEILPGFEINFIKSRSTNMLVPYDYSSVMHYGRFAF  243 
hAstl    LMHVLGFWHEHTRADRDRYIRVNWNEILPGFEINFIKSQSSNMLTPYDYSSVMHYGRLAF  243 
 
mAstl    SWRGQPTIIPLWTSSVHIGQRWNLSTSDITRVCRLYNCSRSVPDSHGRGFEAQSDGSSLT  303 
hAstl    SRRGLPTITPLWAPSVHIGQRWNLSASDITRVLKLYGCSPSGPRPRGRGSHAHSTGRSPA  303 
 
mAstl    PASISRLQRLLEALSEESGSSAPSGSRTGGQSI-AGLGNSQQGWEHPPQSTFSVGALARP  362 
hAstl    PASLS-LQRLLEALSAESRSPDPSGSSAGGQPVPAGPGESPHGWESPALKKLSAEASARQ  362 
 
mAstl    PQMLADASKSGPGAGADSLSLEQFQLAQAPTVPLALFPEARDKPAPIQDAFERLAPLPGG  422 
hAstl    PQTLASSPRSRPGAGAPGVAQEQSWLAGVSTKPTVPSSEAGIQPVPVQGS----PALPGG  418 
 
mAstl    CAPGSHIREVPRD  435 
hAstl    CVPRNHFKGMSED  431 
 
 
Figure S5. Alignment of murine (m) and human (h) ovastacin (Astl) coding sequence, showing 67% 
identical and 75% similar amino acids. Species are noted on the left. Similar residues conserved in the two 
sequences are printed as white letters on black background. A minimum number of gaps, indicated by hyphens, 
has been introduced to maximize alignments. Alignments were produced using the web based alignment service 
BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and default parameters (blastp algorithm, BLOSUM62 Matrix, Gap 
Cost existence:11 extention:1, conditional compositional score matrix adjustment). 
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Figure S6. Fetuin-B deficient mice show ovulation rate comparable to wildtypes. (left) Number of ovulated 
oocytes after mating triggered ovulation and hormonal stimulation in C57BL/6 and (right) DBA/2 mice. Pairwise 
two-sided t test, ns = not significant, * p<0.05 
 
 
  
 
 
Figure S7. Premature zona pellucida (ZP) hardening of fetuin-B deficient oocytes at DBA/2 background. 
(A) Diameter of unfertilized wildtype (+/+) oocytes (72.16 ± 1.90 µm, n = 100) and Fetub-/- (-/-) derived oocytes 
(71.83 ± 2.01 µm, n = 100). (B) ZP thickness of unfertilized wildtype oocytes (7.70 ± 0.70 µm, n = 100), Fetub-/- 
derived oocytes (6.19 ± 0.71 µm, n = 100) and wildtype 2-cell stages (6.57 ± 0.58 µm, n = 54). Boxes represents 
the first to the third quartile, band inside shows the median. Whiskers indicate 5-95 percentile. (C) ZP digestion 
time of wildtype oocytes, fetuin-B deficient oocytes and wildtype two-cell embryos (2-cell stage). The ZP digestion 
time was defined as the time required for 50% of the oocytes to become zona free (t50) following α-chymotrypsin 
treatment. Every dot represents one assay performed with at least 20 oocytes harvested from one mouse per 
genotype. (D) Immune detection of ZP2 protein of wildtype oocytes, fetuin-B deficient oocytes and wildtype 2-cell 
embryos. Fetuin-B deficient oocytes were further isolated pre- and post-ovulatory. Pairwise two-sided t test **p < 
0,01, ***p < 0.001, ns = not significant. The horizontal lines depicts (A, B) the mean ± SD or (C) the mean 
(modified from ). 
+/+ -/- +/+ -/-
0
10
20
30
40
50
untreated superovulated
ns *
nu
m
be
r o
f o
oc
yt
es
B6
+/+ -/- +/+ -/-
0
10
20
30
40
50
60
70
untreated superovulated
ns ns
nu
m
be
r o
f o
oc
yt
es
D2
- Supplement - 
105 
 𝑽 𝑷𝑽𝑺 = 𝟏𝟔𝝅 𝒅𝒐𝒐𝒄𝒚𝒕𝒆 + 𝒅𝑷𝑽𝑹 𝟑 − 𝟏𝟔𝝅 𝒅𝒐𝒐𝒄𝒚𝒕𝒆 𝟑 
 
Figure S8. Calculation of perivitelline space volume. Overview drawing of an oocyte illustrates the diameter of 
the oocyte (doocyte), the perivitelline space (dPVS) and the zona pellucida (dZP). Oocyte diameter and diameter of 
the perivitelline space of 137 individual C57BL/6 wildtype oocytes were measured. Perivitelline space volume 
(V(PVS)) of each oocyte was calculated using the given formula. The mean V(PVS) was used for further 
calculation in paragraph 3.3 
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